data_2kxn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.476 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.492 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' THR . . . . . 0.492 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo . . . . . 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.429 HG23 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . 0.429 ' H ' HG23 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' B' ' 150' ' ' VAL . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.43 ' HA ' ' CA ' ' B' ' 121' ' ' GLY . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.432 ' HA ' ' HB1' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.581 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' THR . . . . . 0.415 ' C ' ' H ' ' B' ' 198' ' ' ARG . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.417 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 38.8 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.547 HG23 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . 0.547 ' H ' HG23 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' B' ' 161' ' ' PHE . 3.6 m . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.524 ' CE1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.457 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HB1' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.435 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo . . . . . 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.402 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 . . . . . 0 CA--C 1.526 0.046 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.446 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.461 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.488 HG23 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . 0.488 ' H ' HG23 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' B' ' 159' ' ' ARG . 53.8 t . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . 0.517 ' H ' ' CG1' ' B' ' 150' ' ' VAL . 85.7 mtt-85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.42 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.421 ' HA ' ' CE2' ' B' ' 123' ' ' PHE . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.405 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.405 ' HD2' ' HG3' ' B' ' 198' ' ' ARG . 73.9 Cg_endo . . . . . 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.439 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.511 HD23 ' H ' ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.474 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 . . . . . 0 N--CA 1.461 0.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.466 ' CE1' ' CG1' ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.445 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.664 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.435 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.459 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.464 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.464 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.405 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 119.702 -0.189 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . 0.475 ' H ' HG23 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.454 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.454 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.42 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.446 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . 0.425 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.432 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . 0.498 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.498 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.513 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.501 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . 0.423 ' H ' HD21 ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.423 HG11 ' CE1' ' B' ' 161' ' ' PHE . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.46 ' HA ' ' HA2' ' B' ' 121' ' ' GLY . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . 0.4 HG23 ' HG ' ' B' ' 126' ' ' SER . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . 0.465 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 C--O 1.228 -0.069 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.494 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . 0.492 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . 0.492 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.501 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.451 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo . . . . . 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.26 0.076 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' SER . . . . . 0.426 ' C ' ' H ' ' B' ' 128' ' ' TYR . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' LEU . . . . . 0.411 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 126' ' ' SER . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' B' ' 161' ' ' PHE . 65.1 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' B' ' 161' ' ' PHE . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' B' ' 193' ' ' PHE . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' PHE . . . . . 0.435 ' H ' ' CG ' ' B' ' 192' ' ' ASP . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' SER . . . . . 0.478 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' B' ' 194' ' ' SER . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' ARG . . . . . 0.446 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.747 0 O4'-C1'-N19 111.738 3.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.258 1 C5'-C4'-C3' 108.885 -4.41 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.204 1 P-O3'-C3' 124.854 4.295 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.513 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.124 0 O4'-C1'-N19 111.862 3.662 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.415 " O2'" ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 C5'-C4'-C3' 107.212 -5.525 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.423 " H5'" ' C6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 N19-C1'-C2' 118.912 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -152.21 166.34 32.05 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.116 0.566 . . . . 0.0 109.736 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.31 172.51 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 C-N-CA 123.399 0.679 . . . . 0.0 110.599 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.71 13.5 0.16 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.53 176.05 10.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 110.845 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -138.25 -8.24 1.53 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.129 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.46 -179.59 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.974 0.51 . . . . 0.0 110.598 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -52.73 113.6 4.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.268 1.027 . . . . 0.0 112.18 -175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.27 53.72 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.087 3.858 . . . . 0.0 111.586 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -134.3 54.16 11.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 157.66 53.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.155 2.57 . . . . 0.0 110.516 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -159.99 -23.99 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m -144.34 0.09 1.01 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.223 0.609 . . . . 0.0 111.695 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.476 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.476 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 p -117.27 151.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.06 -174.63 3.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.796 2.439 . . . . 0.0 107.667 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.476 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 38.5 t70 -90.21 168.29 12.05 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 122.257 1.027 . . . . 0.0 111.149 175.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.476 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 67.6 mt-30 -83.8 -25.52 30.34 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.857 1.663 . . . . 0.0 113.203 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -135.69 -61.05 0.73 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 11.8 t -153.25 -154.93 0.56 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.595 0.358 . . . . 0.0 110.931 -170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 57.39 24.44 10.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.308 1.043 . . . . 0.0 111.605 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 55.51 178.32 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.417 1.487 . . . . 0.0 113.193 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -60.22 143.9 51.47 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.169 1.388 . . . . 0.0 112.43 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.47 -21.17 61.26 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.492 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.492 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.455 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo -59.47 156.99 33.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 129.737 3.215 . . . . 0.0 113.255 179.598 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . 0.424 ' C2 ' ' C5 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 111.099 2.899 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.483 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.411 -3.465 0 O4'-C1'-N19 111.543 3.343 OUTLIER-EPSILON 0.393 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.483 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 O4'-C1'-N19 112.725 4.525 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.475 " H4'" ' CD ' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.851 1 C5'-C4'-C3' 109.097 -4.269 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.496 ' C5 ' ' CZ ' ' B' ' 163' ' ' PHE . . . . . . . . 0 C2'--C1' 1.5 -2.832 3 O4'-C1'-N19 116.946 8.746 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.409 ' H6 ' " O2'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 N19-C1'-C2' 119.159 3.599 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -142.28 5.8 1.68 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.861 0.464 . . . . 0.0 111.541 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.57 168.66 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.494 0.718 . . . . 0.0 109.865 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.46 -173.29 45.32 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.84 152.67 7.0 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.247 1.022 . . . . 0.0 111.089 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -75.85 47.57 0.43 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.851 2.06 . . . . 0.0 110.074 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.89 15.45 1.55 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.166 0.987 . . . . 0.0 111.896 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 56.87 55.05 7.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.48 10.06 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.243 3.295 . . . . 0.0 112.74 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -147.04 147.26 28.63 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.706 -0.621 . . . . 0.0 109.914 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.19 161.5 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.133 3.222 . . . . 0.0 113.187 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.49 166.33 33.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m -135.37 8.09 3.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.932 1.293 . . . . 0.0 110.387 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.581 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.429 HG23 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . 0.429 ' H ' HG23 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . 0.445 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.5 HG12 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p -125.89 64.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' B' ' 158' ' ' SER . 0.1 OUTLIER -62.63 173.1 1.36 Allowed 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 -164.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.4 152.32 45.07 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -80.48 5.62 14.67 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.791 2.436 . . . . 0.0 113.069 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.52 -56.99 14.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.622 0.725 . . . . 0.0 110.279 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -157.3 21.36 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.018 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -134.21 29.38 3.69 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.45 0.7 . . . . 0.0 112.651 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.401 ' HB3' ' H ' ' B' ' 158' ' ' SER . 62.6 mtt180 51.2 -149.71 0.3 Allowed 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.403 0.62 . . . . 0.0 112.547 177.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' B' ' 151' ' ' TYR . 16.0 t 46.58 -136.43 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.09 2.156 . . . . 0.0 113.454 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.475 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 11.1 mmp_? -127.14 -57.83 1.3 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.626 1.103 . . . . 0.0 113.933 -169.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.5 ' CE2' HG12 ' B' ' 150' ' ' VAL . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.496 ' CZ ' ' C5 ' ' A' ' 5' ' ' ' A' . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.423 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.432 ' HA ' ' HB1' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . 0.432 ' HB1' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . 0.444 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.581 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.415 ' C ' ' H ' ' B' ' 198' ' ' ARG . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.417 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.433 ' HA ' ' C4 ' ' A' ' 5' ' ' ' A' . 38.8 Cg_endo -61.61 157.98 39.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 129.346 3.059 . . . . 0.0 113.493 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 0 O4'-C1'-N19 111.805 3.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.566 HO2' ' P ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.412 -3.423 0 C4'-C3'-C2' 98.752 -3.948 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.566 ' P ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 P-O3'-C3' 126.425 5.605 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.454 " H4'" ' CD ' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.838 0 C5'-C4'-C3' 109.886 -3.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.729 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 C2'--C1' 1.502 -2.561 3 O4'-C1'-N19 116.962 8.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.409 ' H5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C3'-C2'-C1' 104.428 3.254 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -144.02 23.94 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.566 0.747 . . . . 0.0 110.932 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.14 17.48 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.526 0.731 . . . . 0.0 111.272 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.91 176.12 40.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -152.13 168.44 25.28 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.074 0.549 . . . . 0.0 109.872 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -154.92 159.88 40.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.434 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . 0.411 ' H ' HD12 ' B' ' 195' ' ' ILE . . . -154.17 -85.48 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.035 0.534 . . . . 0.0 109.721 177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.674 ' H ' ' HD2' ' B' ' 114' ' ' PRO . 60.1 t30 -165.53 -43.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.674 ' HD2' ' H ' ' B' ' 113' ' ' ASN . 90.0 Cg_endo -76.92 169.45 21.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.214 1.943 . . . . 0.0 112.981 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' B' ' 195' ' ' ILE . 17.2 t70 -152.28 140.87 13.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.2 1.0 . . . . 0.0 108.772 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.18 6.93 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.675 2.917 . . . . 0.0 114.786 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -144.24 174.01 11.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.135 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -71.57 42.04 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.115 1.766 . . . . 0.0 112.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.421 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.544 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.544 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.547 HG23 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . 0.547 ' H ' HG23 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . 0.414 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.524 HG23 ' CE1' ' B' ' 161' ' ' PHE . 3.6 m -123.1 55.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -58.66 -169.63 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.961 2.505 . . . . 0.0 116.976 -169.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.412 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 25.1 t70 -45.7 165.7 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.412 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 11.5 pt20 -127.8 16.07 6.9 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.148 2.179 . . . . 0.0 114.166 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . 0.465 ' C ' ' H ' ' B' ' 156' ' ' ARG . 55.3 mt-30 -57.2 -51.82 67.79 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.226 0.921 . . . . 0.0 109.741 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 40.8 m -69.81 15.19 0.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.177 1.391 . . . . 0.0 112.058 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.465 ' H ' ' C ' ' B' ' 154' ' ' GLN . 88.4 mmt-85 58.76 18.27 5.86 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.335 1.454 . . . . 0.0 113.199 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -83.49 -175.17 5.69 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.806 0.842 . . . . 0.0 110.338 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 16.1 m 4.66 -125.84 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 130.966 3.706 . . . . 0.0 116.54 175.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.454 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 4.6 mmp_? -141.72 -68.22 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.583 -0.698 . . . . 0.0 112.172 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.524 ' CE1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.457 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HB1' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . 0.436 ' HB1' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.436 ' H ' ' HB2' ' B' ' 115' ' ' ASP . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.544 ' CG2' ' H62' ' A' ' 5' ' ' ' A' . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.435 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo -55.91 125.9 20.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.729 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 18.0 t60 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.505 2.722 . . . . 0.0 114.008 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.891 0 C5'-C4'-C3' 111.277 -2.815 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.468 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 109.45 -4.033 OUTLIER-EPSILON 0.642 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.468 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 P-O3'-C3' 126.827 5.939 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.488 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.411 -3.497 0 P-O3'-C3' 124.145 3.704 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.7 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 C2'--C1' 1.502 -2.609 2 O4'-C1'-N19 115.475 7.275 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.433 ' H5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 C3'-C2'-C1' 104.229 3.032 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . 0.438 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 4.1 t60 -152.18 175.94 12.08 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 109.866 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.438 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 34.6 m -138.11 18.69 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.729 0.812 . . . . 0.0 111.223 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.09 20.32 3.21 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -62.33 166.17 5.28 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.582 0.706 . . . . 0.0 111.573 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -141.6 2.24 1.6 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.26 1.024 . . . . 0.0 110.709 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.94 -176.3 5.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.272 1.029 . . . . 0.0 109.433 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -143.16 126.34 9.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.61 153.26 69.82 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.086 2.524 . . . . 0.0 111.867 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -163.05 147.67 9.17 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.05 134.62 29.72 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.661 2.241 . . . . 0.0 111.718 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . 0.4 HD22 ' HB3' ' B' ' 193' ' ' PHE . 9.2 p30 -151.43 -173.02 4.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.733 0.813 . . . . 0.0 110.702 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.13 23.34 4.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.686 0.794 . . . . 0.0 110.015 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.402 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.4 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . 0.4 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . 0.402 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.65 142.01 38.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -174.74 170.13 3.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.928 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 26.3 t70 -71.52 168.82 16.77 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 122.168 0.985 . . . . 0.0 112.101 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.411 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 54.1 mt-30 -92.79 -9.17 41.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.576 1.951 . . . . 0.0 114.81 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.52 -68.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.026 0.83 . . . . 0.0 112.399 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.509 ' C ' ' H ' ' B' ' 157' ' ' ARG . 85.3 p -154.59 -158.48 0.86 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.998 -173.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -63.27 9.05 0.06 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.249 1.02 . . . . 0.0 112.553 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.4 mtt85 -62.33 -18.67 62.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.735 1.614 . . . . 0.0 111.945 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.7 p -33.59 135.5 0.12 Allowed 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 130.659 3.583 . . . . 0.0 113.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.437 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.4 mtt-85 -60.03 -25.08 65.03 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . 0.402 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . 0.4 ' HB3' HD22 ' B' ' 117' ' ' ASN . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.446 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.461 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo -56.13 148.55 58.74 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.7 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 11.4 t60 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 128.698 2.799 . . . . 0.0 113.048 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.955 0 O4'-C1'-N19 111.07 2.87 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.464 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.153 0 C5'-C4'-C3' 110.6 -3.266 OUTLIER-EPSILON 0.599 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.464 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.412 -3.382 1 P-O3'-C3' 126.577 5.731 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.403 ' N3 ' " C5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.333 2 C5'-C4'-C3' 109.148 -4.235 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.641 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 C2'--C1' 1.503 -2.546 4 O4'-C1'-N19 114.959 6.759 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.403 ' H6 ' " O2'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.521 0 C3'-C2'-C1' 104.403 3.226 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -62.17 -5.54 2.38 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -152.92 156.11 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.632 0.773 . . . . 0.0 109.264 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.52 48.44 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -149.88 172.72 14.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.355 0.597 . . . . 0.0 110.855 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -149.35 6.24 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.526 -174.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.55 -174.56 4.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.936 0.894 . . . . 0.0 109.648 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.538 ' N ' ' CD ' ' B' ' 114' ' ' PRO . 80.1 m-20 -124.27 5.63 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' B' ' 113' ' ' ASN . 84.3 Cg_exo -49.86 165.91 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.368 2.045 . . . . 0.0 113.945 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -140.27 57.98 9.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.566 0.746 . . . . 0.0 110.57 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 158.42 56.72 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.03 2.487 . . . . 0.0 111.051 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -150.29 4.57 0.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.2 0.6 . . . . 0.0 110.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m -138.95 16.28 2.65 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.637 0.775 . . . . 0.0 110.589 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.433 ' HA3' ' N3 ' ' A' ' 2' ' ' ' A' . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.488 HG23 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . 0.488 ' H ' HG23 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.416 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . 0.416 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . 0.428 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.517 ' CG1' ' H ' ' B' ' 159' ' ' ARG . 53.8 t -129.33 135.95 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . 0.744 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -154.55 158.07 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -146.45 171.6 14.79 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.393 1.092 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -126.37 -31.72 2.75 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.018 2.127 . . . . 0.0 112.009 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.72 -62.88 0.11 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.368 0.667 . . . . 0.0 109.647 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 79.9 p -171.33 -20.25 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.29 13.03 3.78 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -134.73 -163.65 1.4 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.514 1.126 . . . . 0.0 110.344 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.744 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -52.2 -152.38 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.649 2.78 . . . . 0.0 111.629 170.406 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.517 ' H ' ' CG1' ' B' ' 150' ' ' VAL . 85.7 mtt-85 -133.13 -88.08 0.42 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.372 -1.455 . . . . 0.0 113.57 -168.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.442 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.444 ' CE1' ' C4 ' ' A' ' 5' ' ' ' A' . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . 0.403 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.421 ' HA ' ' CE2' ' B' ' 123' ' ' PHE . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.422 ' CG2' ' H62' ' A' ' 5' ' ' ' A' . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.405 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.445 ' HA ' ' C4 ' ' A' ' 5' ' ' ' A' . 73.9 Cg_endo -70.39 155.7 63.29 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.641 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 18.7 t60 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.625 2.77 . . . . 0.0 113.468 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.933 0 C5'-C4'-C3' 111.202 -2.865 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.422 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 C5'-C4'-C3' 110.499 -3.334 OUTLIER-EPSILON 0.474 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.422 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.2 1 P-O3'-C3' 124.681 4.151 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.534 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 O4'-C1'-N19 111.927 3.727 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.794 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 O4'--C4' 1.422 -2.594 2 O4'-C1'-N19 116.783 8.583 OUTLIER-DELTA 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.495 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C3'-C2'-C1' 104.582 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -147.77 12.39 1.0 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.082 0.553 . . . . 0.0 111.042 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.89 161.76 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 123.078 0.551 . . . . 0.0 109.937 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 12.21 0.04 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.702 -0.499 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.53 160.93 43.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.903 0.852 . . . . 0.0 110.348 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -151.63 4.66 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.838 0.855 . . . . 0.0 111.886 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.26 9.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.553 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.632 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 58.9 t30 -146.68 -34.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.632 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 50.5 Cg_exo -56.22 165.84 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.652 2.235 . . . . 0.0 111.928 173.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.79 144.16 19.79 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -86.34 177.96 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 124.502 3.468 . . . . 0.0 111.595 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -133.89 4.28 3.54 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.66 1.184 . . . . 0.0 111.188 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p -157.64 20.87 0.28 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.463 0.705 . . . . 0.0 111.41 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.439 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.439 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.511 ' H ' HD23 ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.474 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.466 ' CG1' ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER -80.91 129.46 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 8.3 p90 172.18 -177.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.351 2.66 . . . . 0.0 108.133 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.36 168.34 16.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 122.535 1.159 . . . . 0.0 113.166 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.97 10.85 0.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.759 2.424 . . . . 0.0 113.813 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -66.58 -62.85 1.24 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 111.105 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.515 ' C ' ' H ' ' B' ' 157' ' ' ARG . 23.2 t -172.6 -165.59 0.33 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.904 1.282 . . . . 0.0 107.818 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.19 7.33 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.248 0.619 . . . . 0.0 111.856 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.515 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.0 mtt180 -65.01 -19.98 66.27 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.253 1.821 . . . . 0.0 112.277 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 p -34.94 134.83 0.22 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 129.625 3.17 . . . . 0.0 112.996 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.438 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 84.1 mtt-85 -62.11 -21.97 65.44 Favored 'General case' 0 C--N 1.338 0.084 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.466 ' CE1' ' CG1' ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . 0.436 ' HB2' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.445 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.664 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.664 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.435 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo -57.46 152.86 44.6 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.794 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 13.1 t60 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.831 2.852 . . . . 0.0 112.957 176.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.267 3.067 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 O4'-C1'-N19 111.927 3.727 OUTLIER-EPSILON 0.56 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.099 2 O4'-C1'-N19 112.353 4.153 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.558 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.351 0 C4'-C3'-C2' 99.554 -3.146 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.78 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 116.766 8.566 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.466 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 C3'-C2'-C1' 104.762 3.624 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -154.47 174.35 15.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.228 0.611 . . . . 0.0 110.379 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.08 160.11 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.997 0.519 . . . . 0.0 109.959 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.43 48.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -152.17 165.35 35.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -150.55 0.52 0.43 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.82 0.848 . . . . 0.0 111.889 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.16 -179.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.302 0.641 . . . . 0.0 111.774 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.659 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 21.6 t-20 -158.21 -33.31 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . 0.659 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 65.6 Cg_exo -54.55 -17.19 12.22 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.174 2.583 . . . . 0.0 115.101 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.55 123.1 84.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.361 0.528 . . . . 0.0 110.875 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.11 155.25 47.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.185 2.59 . . . . 0.0 110.244 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.81 162.39 32.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.637 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.29 12.31 3.66 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.251 1.021 . . . . 0.0 110.448 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.459 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.459 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.464 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t -96.03 119.12 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -173.74 170.28 4.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.866 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.534 ' H ' ' HA ' ' B' ' 158' ' ' SER . 10.4 t70 -134.83 -173.73 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.95 0.9 . . . . 0.0 110.578 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.468 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 15.7 pt20 -119.27 -18.29 8.65 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.167 1.387 . . . . 0.0 112.735 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -130.83 -55.14 1.06 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.551 0.741 . . . . 0.0 111.374 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 36.7 t -56.3 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.249 1.019 . . . . 0.0 110.341 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 40.41 32.66 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.787 1.635 . . . . 0.0 113.492 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 52.72 179.54 0.02 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 113.469 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.534 ' HA ' ' H ' ' B' ' 152' ' ' ASP . 22.9 p -57.69 127.88 34.24 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.987 1.315 . . . . 0.0 112.462 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.412 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.3 mtt-85 -67.5 -22.77 65.43 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.464 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.595 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.405 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.469 HG23 ' H62' ' A' ' 5' ' ' ' A' . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 156.16 50.33 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.78 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 15.5 t60 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 129.056 2.942 . . . . 0.0 113.163 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 O4'-C1'-N19 111.369 3.169 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.52 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.257 0 O4'-C1'-N19 111.978 3.778 OUTLIER-EPSILON 0.649 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.52 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.277 1 P-O3'-C3' 126.696 5.83 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.451 " H4'" ' HD2' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.414 -3.246 1 C5'-C4'-C3' 109.375 -4.083 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.472 ' C5 ' ' CE2' ' B' ' 163' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -2.958 2 O4'-C1'-N19 115.466 7.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.408 ' H6 ' " O2'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C3'-C2'-C1' 104.25 3.055 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 54.4 t60 56.06 22.53 5.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.488 1.115 . . . . 0.0 113.81 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.03 10.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 121.982 -0.449 . . . . 0.0 111.11 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -177.24 40.52 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -145.32 125.03 13.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.126 0.965 . . . . 0.0 110.488 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -55.62 -9.17 0.47 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.05 2.14 . . . . 0.0 113.299 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 12.89 2.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -158.83 134.04 5.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 118.51 0.596 . . . . 0.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.78 170.99 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.71 2.94 . . . . 0.0 111.163 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.715 ' H ' ' HD2' ' B' ' 116' ' ' PRO . 38.4 t70 -156.29 -38.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . 0.715 ' HD2' ' H ' ' B' ' 115' ' ' ASP . 47.9 Cg_endo -82.65 176.54 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.14 1.893 . . . . 0.0 111.671 -176.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -149.46 4.48 0.6 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.934 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m -142.8 14.89 1.93 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.916 0.886 . . . . 0.0 111.311 -174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.42 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' THR . . . . . 0.475 HG23 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . 0.475 ' H ' HG23 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.454 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER -79.8 125.13 38.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 3.3 p90 165.22 -177.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 129.103 2.961 . . . . 0.0 109.017 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.368 1.08 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.19 12.35 0.75 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.357 2.263 . . . . 0.0 113.818 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -69.16 -66.49 0.57 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.835 0.743 . . . . 0.0 110.651 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' SER . . . . . 0.508 ' C ' ' H ' ' B' ' 157' ' ' ARG . 77.1 p -166.78 -163.53 0.57 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 109.116 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.03 7.48 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 112.153 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.508 ' H ' ' C ' ' B' ' 155' ' ' SER . 36.7 mtt180 -64.82 -19.36 65.81 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.553 1.541 . . . . 0.0 112.611 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -36.33 140.46 0.13 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 129.371 3.069 . . . . 0.0 112.73 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.451 ' HD2' " H4'" ' A' ' 4' ' ' ' A' . 50.0 mmt-85 -60.17 -23.49 63.99 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.454 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.472 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.446 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . 0.425 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.432 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo -59.51 157.16 32.82 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 129.824 3.25 . . . . 0.0 113.106 179.064 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 111.091 -2.939 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.426 HO2' ' HA2' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.081 0 O4'-C1'-N19 111.83 3.63 OUTLIER-EPSILON 0.627 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.425 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.962 1 P-O3'-C3' 126.59 5.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.566 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.007 0 O4'-C1'-N19 111.527 3.327 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.424 " H1'" ' H5 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.499 -2.919 2 O4'-C1'-N19 114.489 6.289 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.424 ' H5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.88 0 N19-C1'-C2' 118.771 3.357 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.44 0.162 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -152.31 174.2 14.1 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.506 0.722 . . . . 0.0 110.066 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.89 -0.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 123.186 0.594 . . . . 0.0 111.134 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.1 -23.62 2.08 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -47.94 103.62 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.883 1.273 . . . . 0.0 112.305 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 55.33 26.56 8.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.02 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.23 16.04 1.33 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.242 0.617 . . . . 0.0 112.035 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -157.86 151.92 19.92 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -65.01 168.02 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.037 2.491 . . . . 0.0 111.476 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.49 147.54 95.2 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -79.49 -168.96 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.86 3.706 . . . . 0.0 110.286 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -140.27 11.29 2.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.955 0.502 . . . . 0.0 110.574 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m -138.83 12.1 2.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.266 0.626 . . . . 0.0 112.067 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . 0.498 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.513 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.426 ' HA2' HO2' ' A' ' 2' ' ' ' A' . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.96 144.06 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . 0.433 ' HB2' ' CA ' ' B' ' 158' ' ' SER . 8.1 p90 -168.65 -50.38 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.79 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 12.0 t70 43.03 -173.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.436 2.294 . . . . 0.0 115.042 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.572 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 72.7 mt-30 -73.04 21.19 0.07 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.857 2.463 . . . . 0.0 112.116 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' B' ' 152' ' ' ASP . 91.9 mm-40 -55.17 -50.49 69.18 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.309 1.043 . . . . 0.0 111.868 -175.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.7 m -132.18 -173.48 3.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.276 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -65.98 -2.46 4.01 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.4 0.68 . . . . 0.0 112.753 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 171.32 18.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.008 1.323 . . . . 0.0 111.307 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.433 ' CA ' ' HB2' ' B' ' 151' ' ' TYR . 8.2 p -73.48 147.87 43.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.086 1.754 . . . . 0.0 112.455 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.447 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 84.9 mtt-85 -73.02 -29.8 63.28 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.421 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.498 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.513 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.425 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo -57.47 157.74 21.54 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 129.575 3.15 . . . . 0.0 113.085 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . 0.411 ' C2 ' ' C4 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 O4'-C1'-N19 111.04 2.84 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.578 HO2' ' P ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.043 1 O4'-C1'-N19 112.253 4.053 OUTLIER-EPSILON 0.185 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.578 ' P ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 125.833 5.111 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.415 ' N3 ' H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.968 0 C5'-C4'-C3' 110.743 -3.172 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.739 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 O4'-C1'-N19 116.185 7.985 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.684 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C3'-C2'-C1' 104.997 3.885 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.382 0.134 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -150.98 -178.68 6.74 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 110.094 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.51 7.2 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.81 0.444 . . . . 0.0 111.533 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.27 -13.15 0.1 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.244 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -51.83 123.81 11.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.613 0.707 . . . . 0.0 110.776 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 39.34 38.54 0.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.105 1.762 . . . . 0.0 114.017 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.23 29.76 1.62 Allowed 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.384 1.074 . . . . 0.0 110.939 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.404 ' C ' ' H ' ' B' ' 115' ' ' ASP . 49.9 t-20 -150.84 69.41 8.49 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 122.265 0.226 . . . . 0.0 111.298 -174.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.41 24.96 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 125.176 3.917 . . . . 0.0 112.862 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' B' ' 113' ' ' ASN . 26.1 t0 -136.68 52.04 5.53 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.294 0.638 . . . . 0.0 111.018 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.2 170.55 19.59 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.017 3.145 . . . . 0.0 111.699 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -155.44 154.76 32.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.557 0.743 . . . . 0.0 109.317 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.05 18.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.849 2.06 . . . . 0.0 115.778 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.501 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.501 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . 0.423 HD21 ' H ' ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.445 ' HB ' ' H42' ' A' ' 6' ' ' ' C' . 7.4 p -120.78 138.43 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . 0.626 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -151.34 -168.25 3.04 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -162.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -122.36 173.13 7.83 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.078 0.942 . . . . 0.0 112.034 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -134.84 -37.35 0.82 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.191 1.796 . . . . 0.0 111.919 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -167.95 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 109.063 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 48.8 m -154.85 5.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.301 0.64 . . . . 0.0 112.414 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -122.07 38.88 4.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.541 1.136 . . . . 0.0 109.825 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.66 150.47 2.03 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.626 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 14.0 m -75.01 -32.4 61.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.095 2.158 . . . . 0.0 109.252 168.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.415 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 8.5 mmp_? 158.35 -121.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 130.901 3.68 . . . . 0.0 107.094 173.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.463 ' CZ ' ' C5 ' ' A' ' 5' ' ' ' A' . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . 0.4 HG23 ' HG ' ' B' ' 126' ' ' SER . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.4 163.32 32.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.739 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 7.0 t60 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 127.893 2.477 . . . . 0.0 112.394 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 O4'-C1'-N19 111.699 3.499 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.466 ' N3 ' ' HA3' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.103 1 C5'-C4'-C3' 108.13 -4.914 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.438 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.121 1 P-O3'-C3' 126.868 5.973 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.55 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C3'-C2'-C1' 104.516 3.351 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.692 HO2' ' HB3' ' B' ' 200' ' ' HIS . . . . . . . . 0 C2'--C1' 1.5 -2.829 3 C5'-C4'-C3' 107.277 -5.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.424 ' H5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.775 0 C3'-C2'-C1' 104.177 2.975 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . 0.564 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 8.7 t-80 -73.07 -177.23 2.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.21 0.604 . . . . 0.0 111.18 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.564 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 9.7 p -137.19 12.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.068 0.547 . . . . 0.0 110.954 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -151.34 18.64 0.91 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -48.5 123.0 6.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.46 0.704 . . . . 0.0 111.35 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 40.19 30.34 0.07 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.488 1.915 . . . . 0.0 115.226 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.14 -7.14 0.63 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -162.0 65.57 1.87 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.529 0.331 . . . . 0.0 110.693 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.44 153.27 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.956 3.104 . . . . 0.0 113.74 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -155.32 163.44 24.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.98 1.312 . . . . 0.0 108.611 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.65 162.37 37.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.889 2.393 . . . . 0.0 109.585 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -154.07 162.33 41.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.672 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.33 2.97 8.09 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.026 0.931 . . . . 0.0 111.466 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.494 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . 0.558 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . 0.465 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . 0.431 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -119.96 144.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -134.65 -172.21 2.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.578 2.351 . . . . 0.0 108.796 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -134.15 173.09 11.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.124 0.964 . . . . 0.0 112.685 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -136.36 -14.25 1.74 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.206 1.802 . . . . 0.0 112.855 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -79.28 -53.59 6.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.844 -0.535 . . . . 0.0 110.246 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 18.5 t -70.96 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.216 1.406 . . . . 0.0 109.795 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -127.66 11.15 6.7 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.1 0.96 . . . . 0.0 111.041 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -137.61 174.19 10.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.501 1.12 . . . . 0.0 109.409 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 89.9 p -79.66 158.74 26.95 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.861 1.664 . . . . 0.0 112.265 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.435 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 93.5 mtt-85 -74.31 -18.84 60.65 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.494 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . 0.492 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . 0.492 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.501 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.451 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo -59.02 120.79 8.88 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . 0.692 ' HB3' HO2' ' A' ' 5' ' ' ' A' . 13.5 t60 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 128.679 2.792 . . . . 0.0 113.895 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.1 -2.934 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ' A' . . . . . 0.534 HO2' ' P ' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.416 -3.102 2 O4'-C1'-N19 112.324 4.124 OUTLIER-EPSILON 0.68 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ' G' . . . . . 0.534 ' P ' HO2' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.918 1 P-O3'-C3' 126.678 5.815 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ' A' . . . . . 0.607 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.544 2.629 2 O4'-C1'-N19 113.036 4.836 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ' A' . . . . . 0.431 ' C5 ' ' CE2' ' B' ' 163' ' ' PHE . . . . . . . . 0 C2'--C1' 1.498 -2.993 2 O4'-C1'-N19 116.046 7.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ' C' . . . . . 0.414 ' H5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C3'-C2'-C1' 104.601 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -146.44 169.9 17.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.275 0.63 . . . . 0.0 110.285 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 32.0 m -140.17 9.98 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.498 0.719 . . . . 0.0 111.034 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.45 19.76 0.07 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -149.71 168.57 23.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.201 0.6 . . . . 0.0 110.082 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -145.07 -20.29 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.42 -173.68 3.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.311 0.645 . . . . 0.0 109.925 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -49.26 107.79 0.84 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.533 1.133 . . . . 0.0 112.047 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.74 9.96 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.113 3.209 . . . . 0.0 112.768 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.48 53.43 3.43 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.84 168.63 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.679 2.253 . . . . 0.0 109.694 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -141.6 -3.32 1.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p -152.74 22.54 0.6 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.297 0.499 . . . . 0.0 111.189 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.478 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' GLY . . . . . 0.41 ' HA2' ' N3 ' ' A' ' 2' ' ' ' A' . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' SER . . . . . 0.426 ' C ' ' H ' ' B' ' 128' ' ' TYR . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' LEU . . . . . 0.411 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' TYR . . . . . 0.426 ' H ' ' C ' ' B' ' 126' ' ' SER . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' VAL . . . . . 0.4 ' HB ' ' CD1' ' B' ' 161' ' ' PHE . 65.1 t -84.22 116.52 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -171.45 161.68 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.647 0.592 . . . . 0.0 110.195 175.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -135.61 171.0 15.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.134 0.969 . . . . 0.0 112.437 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.44 -25.71 28.78 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.997 1.719 . . . . 0.0 113.098 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -133.13 -57.42 0.91 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.377 0.671 . . . . 0.0 112.502 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -49.13 102.83 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.853 1.261 . . . . 0.0 110.98 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 39.43 33.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 51.21 179.78 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.59 1.556 . . . . 0.0 112.73 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 10.1 p -58.17 119.38 6.74 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.791 1.236 . . . . 0.0 111.355 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . 0.441 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.9 mtt-85 -66.17 -24.54 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.467 0.307 . . . . 0.0 110.199 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLY . . . . . 0.411 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . 0.432 ' CZ ' ' CE2' ' B' ' 161' ' ' PHE . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' B' ' 193' ' ' PHE . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' PHE . . . . . 0.435 ' H ' ' CG ' ' B' ' 192' ' ' ASP . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' SER . . . . . 0.478 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' B' ' 194' ' ' SER . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' ARG . . . . . 0.446 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo -54.66 159.81 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 18.1 t60 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.512 3.125 . . . . 0.0 113.082 -178.759 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.482 HD12 ' H ' ' B' ' 127' ' ' LEU . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.491 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 182' ' ' MET . . . . . 0.42 ' CG ' HD11 ' B' ' 189' ' ' ILE . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.42 HD11 ' CG ' ' B' ' 182' ' ' MET . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 195' ' ' ILE . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.503 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo . . . . . 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 119' ' ' CYS . . . . . 0.446 ' C ' HD12 ' B' ' 120' ' ' LEU . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.446 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.443 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ARG . . . . . 0.443 ' H ' HG22 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.529 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.433 ' HA ' ' CA ' ' B' ' 121' ' ' GLY . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.555 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 38.8 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 119' ' ' CYS . . . . . 0.458 ' C ' HD12 ' B' ' 120' ' ' LEU . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.458 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.573 HG22 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' B' ' 161' ' ' PHE . 3.6 m . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.499 ' CD1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.485 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.464 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo . . . . . 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.41 HG21 HD22 ' B' ' 134' ' ' LEU . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.456 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.41 HD22 HG21 ' B' ' 122' ' ' VAL . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 . . . . . 0 CA--C 1.526 0.046 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 188' ' ' ARG . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.441 HG23 HG23 ' B' ' 196' ' ' THR . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 195' ' ' ILE . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 119' ' ' CYS . . . . . 0.437 ' C ' HD12 ' B' ' 120' ' ' LEU . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.437 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' VAL . . . . . 0.426 HG21 HD22 ' B' ' 134' ' ' LEU . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.522 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ARG . . . . . 0.522 ' H ' HG22 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.426 HD22 HG21 ' B' ' 122' ' ' VAL . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.422 HG11 ' CE1' ' B' ' 161' ' ' PHE . 53.8 t . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' B' ' 198' ' ' ARG . 73.9 Cg_endo . . . . . 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 120' ' ' LEU . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.529 HD22 ' H ' ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' THR . . . . . 0.509 HG22 ' CD2' ' B' ' 134' ' ' LEU . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' B' ' 129' ' ' THR . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.441 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 . . . . . 0 N--CA 1.461 0.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.656 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.656 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.419 ' H ' HD23 ' B' ' 125' ' ' LEU . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.5 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.476 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 119.702 -0.189 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 119' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' B' ' 127' ' ' LEU . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 125' ' ' LEU . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' THR . . . . . 0.496 HG22 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ARG . . . . . 0.496 ' H ' HG22 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.496 HG13 ' CD1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.443 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.402 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 119' ' ' CYS . . . . . 0.481 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.51 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.481 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 182' ' ' MET . . . . . 0.422 ' HG2' HD11 ' B' ' 189' ' ' ILE . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' B' ' 182' ' ' MET . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.51 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.424 HG23 HG23 ' B' ' 195' ' ' ILE . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.462 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.48 ' H ' HD12 ' B' ' 127' ' ' LEU . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' LEU . . . . . 0.541 HD22 ' H ' ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' B' ' 161' ' ' PHE . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.469 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.501 HG23 HG23 ' B' ' 196' ' ' THR . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.501 HG23 HG23 ' B' ' 195' ' ' ILE . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.402 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 56.3 Cg_endo . . . . . 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 124' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 126' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' B' ' 187' ' ' ARG . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.463 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 C--O 1.228 -0.069 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.465 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 187' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' B' ' 126' ' ' SER . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 193' ' ' PHE . . . . . 0.485 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.5 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo . . . . . 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.26 0.076 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 120' ' ' LEU . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' LEU . . . . . 0.413 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 150' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' B' ' 161' ' ' PHE . 65.1 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 160' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 163' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' B' ' 194' ' ' SER . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' MET . . . . . 0.411 ' HG2' HD11 ' B' ' 189' ' ' ILE . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' B' ' 182' ' ' MET . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 194' ' ' SER . . . . . 0.485 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 196' ' ' THR . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 196' ' ' THR . . . . . 0.476 HG23 HG23 ' B' ' 195' ' ' ILE . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 198' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 199' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.747 0 O4'-C1'-N19 111.738 3.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.258 1 C5'-C4'-C3' 108.885 -4.41 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.427 ' N2 ' HG22 ' B' ' 195' ' ' ILE . . . . . . . . 0 O4'--C4' 1.415 -3.204 1 P-O3'-C3' 124.854 4.295 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.465 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.124 0 O4'-C1'-N19 111.862 3.662 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.481 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 C5'-C4'-C3' 107.212 -5.525 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.481 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 N19-C1'-C2' 118.912 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -152.21 166.34 32.05 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.116 0.566 . . . . 0.0 109.736 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.31 172.51 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 C-N-CA 123.399 0.679 . . . . 0.0 110.599 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.71 13.5 0.16 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.53 176.05 10.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 110.845 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -138.25 -8.24 1.53 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.129 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.46 -179.59 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.974 0.51 . . . . 0.0 110.598 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -52.73 113.6 4.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.268 1.027 . . . . 0.0 112.18 -175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.27 53.72 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.087 3.858 . . . . 0.0 111.586 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -134.3 54.16 11.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 157.66 53.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.155 2.57 . . . . 0.0 110.516 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -159.99 -23.99 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m -144.34 0.09 1.01 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.223 0.609 . . . . 0.0 111.695 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.482 HD12 ' H ' ' B' ' 127' ' ' LEU . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.491 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.437 ' HB ' ' H41' ' A' ' 6' ' ' ' C' . 15.0 p -117.27 151.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.06 -174.63 3.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.796 2.439 . . . . 0.0 107.667 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 38.5 t70 -90.21 168.29 12.05 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 122.257 1.027 . . . . 0.0 111.149 175.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.468 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 67.6 mt-30 -83.8 -25.52 30.34 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.857 1.663 . . . . 0.0 113.203 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -135.69 -61.05 0.73 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 11.8 t -153.25 -154.93 0.56 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.595 0.358 . . . . 0.0 110.931 -170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 57.39 24.44 10.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.308 1.043 . . . . 0.0 111.605 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 55.51 178.32 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.417 1.487 . . . . 0.0 113.193 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -60.22 143.9 51.47 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.169 1.388 . . . . 0.0 112.43 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.47 -21.17 61.26 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' MET . . . . . 0.42 ' CG ' HD11 ' B' ' 189' ' ' ILE . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.42 HD11 ' CG ' ' B' ' 182' ' ' MET . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 195' ' ' ILE . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.503 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo -59.47 156.99 33.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 129.737 3.215 . . . . 0.0 113.255 179.598 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . 0.424 ' C2 ' ' C5 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 111.099 2.899 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.452 ' C4 ' ' HD2' ' B' ' 190' ' ' ARG . . . . . . . . 0 O4'--C4' 1.411 -3.465 0 O4'-C1'-N19 111.543 3.343 OUTLIER-EPSILON 0.393 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.429 ' N2 ' ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 O4'-C1'-N19 112.725 4.525 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.48 " H4'" ' HD3' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.851 1 C5'-C4'-C3' 109.097 -4.269 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.496 ' C5 ' ' CZ ' ' B' ' 163' ' ' PHE . . . . . . . . 0 C2'--C1' 1.5 -2.832 3 O4'-C1'-N19 116.946 8.746 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.415 ' H6 ' " O2'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 N19-C1'-C2' 119.159 3.599 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -142.28 5.8 1.68 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.861 0.464 . . . . 0.0 111.541 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.57 168.66 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.494 0.718 . . . . 0.0 109.865 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.46 -173.29 45.32 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.84 152.67 7.0 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.247 1.022 . . . . 0.0 111.089 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -75.85 47.57 0.43 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.851 2.06 . . . . 0.0 110.074 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.89 15.45 1.55 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.166 0.987 . . . . 0.0 111.896 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 56.87 55.05 7.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.48 10.06 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.243 3.295 . . . . 0.0 112.74 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -147.04 147.26 28.63 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.706 -0.621 . . . . 0.0 109.914 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.19 161.5 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.133 3.222 . . . . 0.0 113.187 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.49 166.33 33.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m -135.37 8.09 3.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.932 1.293 . . . . 0.0 110.387 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' CYS . . . . . 0.446 ' C ' HD12 ' B' ' 120' ' ' LEU . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.446 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.443 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ARG . . . . . 0.443 ' H ' HG22 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p -125.89 64.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.413 ' O ' ' HB3' ' B' ' 158' ' ' SER . 0.1 OUTLIER -62.63 173.1 1.36 Allowed 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 -164.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.4 152.32 45.07 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -80.48 5.62 14.67 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.791 2.436 . . . . 0.0 113.069 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.52 -56.99 14.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.622 0.725 . . . . 0.0 110.279 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -157.3 21.36 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.018 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -134.21 29.38 3.69 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.45 0.7 . . . . 0.0 112.651 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 51.2 -149.71 0.3 Allowed 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.403 0.62 . . . . 0.0 112.547 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 151' ' ' TYR . 16.0 t 46.58 -136.43 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.09 2.156 . . . . 0.0 113.454 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.48 ' HD3' " H4'" ' A' ' 4' ' ' ' A' . 11.1 mmp_? -127.14 -57.83 1.3 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.626 1.103 . . . . 0.0 113.933 -169.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.529 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.496 ' CZ ' ' C5 ' ' A' ' 5' ' ' ' A' . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' B' ' 188' ' ' ARG . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' ARG . . . . . 0.452 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.555 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.405 HG23 ' N7 ' ' A' ' 4' ' ' ' A' . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 38.8 Cg_endo -61.61 157.98 39.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 129.346 3.059 . . . . 0.0 113.493 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 0 O4'-C1'-N19 111.805 3.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.412 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.412 -3.423 0 C4'-C3'-C2' 98.752 -3.948 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.412 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 P-O3'-C3' 126.425 5.605 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.456 " H4'" ' CD ' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.838 0 C5'-C4'-C3' 109.886 -3.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.695 ' H62' HG23 ' B' ' 196' ' ' THR . . . . . . . . 0 C2'--C1' 1.502 -2.561 3 O4'-C1'-N19 116.962 8.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.607 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C3'-C2'-C1' 104.428 3.254 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -144.02 23.94 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.566 0.747 . . . . 0.0 110.932 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.14 17.48 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.526 0.731 . . . . 0.0 111.272 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.91 176.12 40.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -152.13 168.44 25.28 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.074 0.549 . . . . 0.0 109.872 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -154.92 159.88 40.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.434 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.17 -85.48 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.035 0.534 . . . . 0.0 109.721 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.762 ' H ' ' HD2' ' B' ' 114' ' ' PRO . 60.1 t30 -165.53 -43.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' B' ' 113' ' ' ASN . 90.0 Cg_endo -76.92 169.45 21.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.214 1.943 . . . . 0.0 112.981 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' B' ' 195' ' ' ILE . 17.2 t70 -152.28 140.87 13.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.2 1.0 . . . . 0.0 108.772 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.18 6.93 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.675 2.917 . . . . 0.0 114.786 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -144.24 174.01 11.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.135 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -71.57 42.04 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.115 1.766 . . . . 0.0 112.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' CYS . . . . . 0.458 ' C ' HD12 ' B' ' 120' ' ' LEU . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.458 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.573 HG22 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' B' ' 161' ' ' PHE . 3.6 m -123.1 55.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -58.66 -169.63 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.961 2.505 . . . . 0.0 116.976 -169.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 25.1 t70 -45.7 165.7 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.414 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 11.5 pt20 -127.8 16.07 6.9 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.148 2.179 . . . . 0.0 114.166 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' B' ' 156' ' ' ARG . 55.3 mt-30 -57.2 -51.82 67.79 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.226 0.921 . . . . 0.0 109.741 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 40.8 m -69.81 15.19 0.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.177 1.391 . . . . 0.0 112.058 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' B' ' 154' ' ' GLN . 88.4 mmt-85 58.76 18.27 5.86 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.335 1.454 . . . . 0.0 113.199 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -83.49 -175.17 5.69 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.806 0.842 . . . . 0.0 110.338 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' B' ' 151' ' ' TYR . 16.1 m 4.66 -125.84 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 130.966 3.706 . . . . 0.0 116.54 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.456 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 4.6 mmp_? -141.72 -68.22 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.583 -0.698 . . . . 0.0 112.172 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.499 ' CD1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.485 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.466 ' H ' ' HB2' ' B' ' 115' ' ' ASP . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.695 HG23 ' H62' ' A' ' 5' ' ' ' A' . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.464 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo -55.91 125.9 20.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 200' ' ' HIS . . . . . 0.437 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 18.0 t60 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.505 2.722 . . . . 0.0 114.008 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.891 0 C5'-C4'-C3' 111.277 -2.815 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.422 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 109.45 -4.033 OUTLIER-EPSILON 0.642 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.422 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 P-O3'-C3' 126.827 5.939 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.447 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.411 -3.497 0 P-O3'-C3' 124.145 3.704 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.601 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.502 -2.609 2 O4'-C1'-N19 115.475 7.275 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.601 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 C3'-C2'-C1' 104.229 3.032 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 107' ' ' HIS . . . . . 0.406 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 4.1 t60 -152.18 175.94 12.08 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 109.866 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.406 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 34.6 m -138.11 18.69 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.729 0.812 . . . . 0.0 111.223 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.09 20.32 3.21 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -62.33 166.17 5.28 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.582 0.706 . . . . 0.0 111.573 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -141.6 2.24 1.6 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.26 1.024 . . . . 0.0 110.709 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.94 -176.3 5.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.272 1.029 . . . . 0.0 109.433 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -143.16 126.34 9.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.61 153.26 69.82 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.086 2.524 . . . . 0.0 111.867 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -163.05 147.67 9.17 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.05 134.62 29.72 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.661 2.241 . . . . 0.0 111.718 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' B' ' 193' ' ' PHE . 9.2 p30 -151.43 -173.02 4.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.733 0.813 . . . . 0.0 110.702 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.13 23.34 4.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.686 0.794 . . . . 0.0 110.015 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.41 HG21 HD22 ' B' ' 134' ' ' LEU . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.456 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.41 HD22 HG21 ' B' ' 122' ' ' VAL . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.65 142.01 38.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -174.74 170.13 3.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.928 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 26.3 t70 -71.52 168.82 16.77 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 122.168 0.985 . . . . 0.0 112.101 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.411 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 54.1 mt-30 -92.79 -9.17 41.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.576 1.951 . . . . 0.0 114.81 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.52 -68.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.026 0.83 . . . . 0.0 112.399 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 157' ' ' ARG . 85.3 p -154.59 -158.48 0.86 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.998 -173.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -63.27 9.05 0.06 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.249 1.02 . . . . 0.0 112.553 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.4 mtt85 -62.33 -18.67 62.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.735 1.614 . . . . 0.0 111.945 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.7 p -33.59 135.5 0.12 Allowed 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 130.659 3.583 . . . . 0.0 113.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.441 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.4 mtt-85 -60.03 -25.08 65.03 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 188' ' ' ARG . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' B' ' 117' ' ' ASN . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.441 HG23 HG23 ' B' ' 196' ' ' THR . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 195' ' ' ILE . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo -56.13 148.55 58.74 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 200' ' ' HIS . . . . . 0.43 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 11.4 t60 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 128.698 2.799 . . . . 0.0 113.048 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.955 0 O4'-C1'-N19 111.07 2.87 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.453 ' N3 ' ' HA3' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.415 -3.153 0 C5'-C4'-C3' 110.6 -3.266 OUTLIER-EPSILON 0.599 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.421 ' OP1' " C1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.412 -3.382 1 P-O3'-C3' 126.577 5.731 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.403 ' N3 ' " C5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.333 2 C5'-C4'-C3' 109.148 -4.235 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.629 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.503 -2.546 4 O4'-C1'-N19 114.959 6.759 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.629 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.521 0 C3'-C2'-C1' 104.403 3.226 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -62.17 -5.54 2.38 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -152.92 156.11 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.632 0.773 . . . . 0.0 109.264 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.52 48.44 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -149.88 172.72 14.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.355 0.597 . . . . 0.0 110.855 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -149.35 6.24 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.526 -174.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.55 -174.56 4.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.936 0.894 . . . . 0.0 109.648 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.554 ' H ' ' HD3' ' B' ' 114' ' ' PRO . 80.1 m-20 -124.27 5.63 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' B' ' 113' ' ' ASN . 84.3 Cg_exo -49.86 165.91 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.368 2.045 . . . . 0.0 113.945 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -140.27 57.98 9.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.566 0.746 . . . . 0.0 110.57 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 158.42 56.72 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.03 2.487 . . . . 0.0 111.051 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -150.29 4.57 0.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.2 0.6 . . . . 0.0 110.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m -138.95 16.28 2.65 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.637 0.775 . . . . 0.0 110.589 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' CYS . . . . . 0.437 ' C ' HD12 ' B' ' 120' ' ' LEU . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.437 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' VAL . . . . . 0.426 HG21 HD22 ' B' ' 134' ' ' LEU . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.453 ' HA3' ' N3 ' ' A' ' 2' ' ' ' A' . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.522 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ARG . . . . . 0.522 ' H ' HG22 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.426 HD22 HG21 ' B' ' 122' ' ' VAL . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.549 HG12 ' H ' ' B' ' 159' ' ' ARG . 53.8 t -129.33 135.95 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.779 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -154.55 158.07 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -146.45 171.6 14.79 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.393 1.092 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -126.37 -31.72 2.75 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.018 2.127 . . . . 0.0 112.009 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.72 -62.88 0.11 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.368 0.667 . . . . 0.0 109.647 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 79.9 p -171.33 -20.25 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.29 13.03 3.78 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -134.73 -163.65 1.4 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.514 1.126 . . . . 0.0 110.344 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.779 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -52.2 -152.38 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.649 2.78 . . . . 0.0 111.629 170.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.549 ' H ' HG12 ' B' ' 150' ' ' VAL . 85.7 mtt-85 -133.13 -88.08 0.42 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.372 -1.455 . . . . 0.0 113.57 -168.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' ARG . . . . . 0.418 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.44 ' CG2' ' H62' ' A' ' 5' ' ' ' A' . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' B' ' 198' ' ' ARG . 73.9 Cg_endo -70.39 155.7 63.29 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 200' ' ' HIS . . . . . 0.464 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 18.7 t60 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.625 2.77 . . . . 0.0 113.468 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.933 0 C5'-C4'-C3' 111.202 -2.865 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 C5'-C4'-C3' 110.499 -3.334 OUTLIER-EPSILON 0.474 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.2 1 P-O3'-C3' 124.681 4.151 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.486 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 O4'-C1'-N19 111.927 3.727 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.62 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.594 2 O4'-C1'-N19 116.783 8.583 OUTLIER-DELTA 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.62 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C3'-C2'-C1' 104.582 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -147.77 12.39 1.0 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.082 0.553 . . . . 0.0 111.042 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.89 161.76 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 123.078 0.551 . . . . 0.0 109.937 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 12.21 0.04 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.702 -0.499 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.53 160.93 43.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.903 0.852 . . . . 0.0 110.348 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -151.63 4.66 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.838 0.855 . . . . 0.0 111.886 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.26 9.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.553 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.701 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 58.9 t30 -146.68 -34.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 50.5 Cg_exo -56.22 165.84 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.652 2.235 . . . . 0.0 111.928 173.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.79 144.16 19.79 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -86.34 177.96 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 124.502 3.468 . . . . 0.0 111.595 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -133.89 4.28 3.54 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.66 1.184 . . . . 0.0 111.188 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p -157.64 20.87 0.28 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.463 0.705 . . . . 0.0 111.41 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 120' ' ' LEU . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.529 HD22 ' H ' ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' THR . . . . . 0.509 HG22 ' CD2' ' B' ' 134' ' ' LEU . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' B' ' 129' ' ' THR . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.441 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER -80.91 129.46 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.416 ' HB3' ' H ' ' B' ' 160' ' ' GLY . 8.3 p90 172.18 -177.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.351 2.66 . . . . 0.0 108.133 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.36 168.34 16.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 122.535 1.159 . . . . 0.0 113.166 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.97 10.85 0.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.759 2.424 . . . . 0.0 113.813 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -66.58 -62.85 1.24 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 111.105 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.464 ' C ' ' H ' ' B' ' 157' ' ' ARG . 23.2 t -172.6 -165.59 0.33 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.904 1.282 . . . . 0.0 107.818 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.19 7.33 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.248 0.619 . . . . 0.0 111.856 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.0 mtt180 -65.01 -19.98 66.27 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.253 1.821 . . . . 0.0 112.277 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 p -34.94 134.83 0.22 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 129.625 3.17 . . . . 0.0 112.996 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.438 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 84.1 mtt-85 -62.11 -21.97 65.44 Favored 'General case' 0 C--N 1.338 0.084 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' B' ' 151' ' ' TYR . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.656 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.656 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo -57.46 152.86 44.6 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 13.1 t60 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.831 2.852 . . . . 0.0 112.957 176.968 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.267 3.067 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 O4'-C1'-N19 111.927 3.727 OUTLIER-EPSILON 0.56 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.099 2 O4'-C1'-N19 112.353 4.153 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.56 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.351 0 C4'-C3'-C2' 99.554 -3.146 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.551 ' H62' HG23 ' B' ' 196' ' ' THR . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 116.766 8.566 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.422 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 C3'-C2'-C1' 104.762 3.624 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -154.47 174.35 15.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.228 0.611 . . . . 0.0 110.379 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.08 160.11 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.997 0.519 . . . . 0.0 109.959 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.43 48.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -152.17 165.35 35.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -150.55 0.52 0.43 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.82 0.848 . . . . 0.0 111.889 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.16 -179.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.302 0.641 . . . . 0.0 111.774 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.726 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 21.6 t-20 -158.21 -33.31 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.726 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 65.6 Cg_exo -54.55 -17.19 12.22 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.174 2.583 . . . . 0.0 115.101 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.55 123.1 84.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.361 0.528 . . . . 0.0 110.875 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.11 155.25 47.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.185 2.59 . . . . 0.0 110.244 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.81 162.39 32.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.637 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.29 12.31 3.66 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.251 1.021 . . . . 0.0 110.448 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.419 ' H ' HD23 ' B' ' 125' ' ' LEU . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.5 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.476 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t -96.03 119.12 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -173.74 170.28 4.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.866 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.521 ' H ' ' HA ' ' B' ' 158' ' ' SER . 10.4 t70 -134.83 -173.73 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.95 0.9 . . . . 0.0 110.578 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.457 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 15.7 pt20 -119.27 -18.29 8.65 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.167 1.387 . . . . 0.0 112.735 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -130.83 -55.14 1.06 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.551 0.741 . . . . 0.0 111.374 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 36.7 t -56.3 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.249 1.019 . . . . 0.0 110.341 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 40.41 32.66 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.787 1.635 . . . . 0.0 113.492 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 52.72 179.54 0.02 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 113.469 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 152' ' ' ASP . 22.9 p -57.69 127.88 34.24 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.987 1.315 . . . . 0.0 112.462 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.413 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.3 mtt-85 -67.5 -22.77 65.43 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.551 HG23 ' H62' ' A' ' 5' ' ' ' A' . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 156.16 50.33 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 129.056 2.942 . . . . 0.0 113.163 177.284 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 O4'-C1'-N19 111.369 3.169 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.482 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.257 0 O4'-C1'-N19 111.978 3.778 OUTLIER-EPSILON 0.649 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.482 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.277 1 P-O3'-C3' 126.696 5.83 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.497 " H4'" ' HD2' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.414 -3.246 1 C5'-C4'-C3' 109.375 -4.083 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.594 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -2.958 2 O4'-C1'-N19 115.466 7.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.594 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C3'-C2'-C1' 104.25 3.055 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 54.4 t60 56.06 22.53 5.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.488 1.115 . . . . 0.0 113.81 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.03 10.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 121.982 -0.449 . . . . 0.0 111.11 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -177.24 40.52 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -145.32 125.03 13.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.126 0.965 . . . . 0.0 110.488 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -55.62 -9.17 0.47 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.05 2.14 . . . . 0.0 113.299 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 12.89 2.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -158.83 134.04 5.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 118.51 0.596 . . . . 0.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.78 170.99 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.71 2.94 . . . . 0.0 111.163 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' ASP . . . . . 0.794 ' H ' ' HD2' ' B' ' 116' ' ' PRO . 38.4 t70 -156.29 -38.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' B' ' 115' ' ' ASP . 47.9 Cg_endo -82.65 176.54 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.14 1.893 . . . . 0.0 111.671 -176.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -149.46 4.48 0.6 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.934 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m -142.8 14.89 1.93 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.916 0.886 . . . . 0.0 111.311 -174.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' B' ' 127' ' ' LEU . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 125' ' ' LEU . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' THR . . . . . 0.496 HG22 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ARG . . . . . 0.496 ' H ' HG22 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.496 HG13 ' CD1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER -79.8 125.13 38.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 3.3 p90 165.22 -177.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 129.103 2.961 . . . . 0.0 109.017 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.368 1.08 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.19 12.35 0.75 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.357 2.263 . . . . 0.0 113.818 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -69.16 -66.49 0.57 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.835 0.743 . . . . 0.0 110.651 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' SER . . . . . 0.458 ' C ' ' H ' ' B' ' 157' ' ' ARG . 77.1 p -166.78 -163.53 0.57 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 109.116 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.03 7.48 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 112.153 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 155' ' ' SER . 36.7 mtt180 -64.82 -19.36 65.81 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.553 1.541 . . . . 0.0 112.611 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -36.33 140.46 0.13 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 129.371 3.069 . . . . 0.0 112.73 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.497 ' HD2' " H4'" ' A' ' 4' ' ' ' A' . 50.0 mmt-85 -60.17 -23.49 63.99 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.472 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.402 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo -59.51 157.16 32.82 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 129.824 3.25 . . . . 0.0 113.106 179.064 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 111.091 -2.939 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.081 0 O4'-C1'-N19 111.83 3.63 OUTLIER-EPSILON 0.627 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.408 ' C6 ' ' CG ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -2.962 1 P-O3'-C3' 126.59 5.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.609 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.007 0 O4'-C1'-N19 111.527 3.327 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.578 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.499 -2.919 2 O4'-C1'-N19 114.489 6.289 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.578 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.88 0 N19-C1'-C2' 118.771 3.357 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.44 0.162 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -152.31 174.2 14.1 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.506 0.722 . . . . 0.0 110.066 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.89 -0.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 123.186 0.594 . . . . 0.0 111.134 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.1 -23.62 2.08 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -47.94 103.62 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.883 1.273 . . . . 0.0 112.305 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 55.33 26.56 8.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.02 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.23 16.04 1.33 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.242 0.617 . . . . 0.0 112.035 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.404 ' CG ' ' HD2' ' B' ' 114' ' ' PRO . 10.0 t-20 -157.86 151.92 19.92 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' B' ' 113' ' ' ASN . 51.0 Cg_endo -65.01 168.02 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.037 2.491 . . . . 0.0 111.476 176.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.49 147.54 95.2 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -79.49 -168.96 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.86 3.706 . . . . 0.0 110.286 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -140.27 11.29 2.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.955 0.502 . . . . 0.0 110.574 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m -138.83 12.1 2.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.266 0.626 . . . . 0.0 112.067 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' CYS . . . . . 0.481 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.51 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.96 144.06 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.454 ' HB2' ' CA ' ' B' ' 158' ' ' SER . 8.1 p90 -168.65 -50.38 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.79 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 12.0 t70 43.03 -173.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.436 2.294 . . . . 0.0 115.042 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . 0.562 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 72.7 mt-30 -73.04 21.19 0.07 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.857 2.463 . . . . 0.0 112.116 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -55.17 -50.49 69.18 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.309 1.043 . . . . 0.0 111.868 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.7 m -132.18 -173.48 3.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.276 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -65.98 -2.46 4.01 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.4 0.68 . . . . 0.0 112.753 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 171.32 18.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.008 1.323 . . . . 0.0 111.307 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.454 ' CA ' ' HB2' ' B' ' 151' ' ' TYR . 8.2 p -73.48 147.87 43.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.086 1.754 . . . . 0.0 112.455 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.446 ' HD3' H5'' ' A' ' 4' ' ' ' A' . 84.9 mtt-85 -73.02 -29.8 63.28 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.421 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.481 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 182' ' ' MET . . . . . 0.422 ' HG2' HD11 ' B' ' 189' ' ' ILE . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' B' ' 182' ' ' MET . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.51 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.424 HG23 HG23 ' B' ' 195' ' ' ILE . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo -57.47 157.74 21.54 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 129.575 3.15 . . . . 0.0 113.085 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . 0.411 ' C2 ' ' C4 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 O4'-C1'-N19 111.04 2.84 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.411 ' C4 ' ' C2 ' ' A' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.043 1 O4'-C1'-N19 112.253 4.053 OUTLIER-EPSILON 0.185 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.499 ' C2 ' ' CZ ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 125.833 5.111 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.465 ' N3 ' H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.968 0 C5'-C4'-C3' 110.743 -3.172 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.682 " H1'" ' C5 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 O4'-C1'-N19 116.185 7.985 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.682 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C3'-C2'-C1' 104.997 3.885 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.382 0.134 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -150.98 -178.68 6.74 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 110.094 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.51 7.2 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.81 0.444 . . . . 0.0 111.533 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.27 -13.15 0.1 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.244 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -51.83 123.81 11.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.613 0.707 . . . . 0.0 110.776 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 39.34 38.54 0.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.105 1.762 . . . . 0.0 114.017 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.23 29.76 1.62 Allowed 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.384 1.074 . . . . 0.0 110.939 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -150.84 69.41 8.49 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 122.265 0.226 . . . . 0.0 111.298 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.41 24.96 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 125.176 3.917 . . . . 0.0 112.862 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -136.68 52.04 5.53 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.294 0.638 . . . . 0.0 111.018 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.2 170.55 19.59 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.017 3.145 . . . . 0.0 111.699 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -155.44 154.76 32.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.557 0.743 . . . . 0.0 109.317 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.05 18.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.849 2.06 . . . . 0.0 115.778 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.462 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.48 ' H ' HD12 ' B' ' 127' ' ' LEU . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' LEU . . . . . 0.541 ' H ' HD22 ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.452 ' HB ' ' H41' ' A' ' 6' ' ' ' C' . 7.4 p -120.78 138.43 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.67 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -151.34 -168.25 3.04 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -162.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -122.36 173.13 7.83 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.078 0.942 . . . . 0.0 112.034 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -134.84 -37.35 0.82 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.191 1.796 . . . . 0.0 111.919 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -167.95 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 109.063 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 48.8 m -154.85 5.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.301 0.64 . . . . 0.0 112.414 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -122.07 38.88 4.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.541 1.136 . . . . 0.0 109.825 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -49.66 150.47 2.03 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.009 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 14.0 m -75.01 -32.4 61.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.095 2.158 . . . . 0.0 109.252 168.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.43 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 8.5 mmp_? 158.35 -121.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 130.901 3.68 . . . . 0.0 107.094 173.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.469 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.501 HG23 HG23 ' B' ' 196' ' ' THR . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.501 HG23 HG23 ' B' ' 195' ' ' ILE . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.402 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 56.3 Cg_endo -66.4 163.32 32.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 127.893 2.477 . . . . 0.0 112.394 178.918 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 O4'-C1'-N19 111.699 3.499 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.462 ' N3 ' ' HA3' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.103 1 C5'-C4'-C3' 108.13 -4.914 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.474 ' N2 ' HG22 ' B' ' 195' ' ' ILE . . . . . . . . 0 O4'--C4' 1.416 -3.121 1 P-O3'-C3' 126.868 5.973 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.502 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C3'-C2'-C1' 104.516 3.351 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.584 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.5 -2.829 3 C5'-C4'-C3' 107.277 -5.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.584 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.775 0 C3'-C2'-C1' 104.177 2.975 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 107' ' ' HIS . . . . . 0.525 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 8.7 t-80 -73.07 -177.23 2.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.21 0.604 . . . . 0.0 111.18 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.525 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 9.7 p -137.19 12.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.068 0.547 . . . . 0.0 110.954 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -151.34 18.64 0.91 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -48.5 123.0 6.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.46 0.704 . . . . 0.0 111.35 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 40.19 30.34 0.07 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.488 1.915 . . . . 0.0 115.226 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.14 -7.14 0.63 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -162.0 65.57 1.87 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.529 0.331 . . . . 0.0 110.693 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.44 153.27 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.956 3.104 . . . . 0.0 113.74 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -155.32 163.44 24.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.98 1.312 . . . . 0.0 108.611 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.65 162.37 37.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.889 2.393 . . . . 0.0 109.585 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -154.07 162.33 41.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.672 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.33 2.97 8.09 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.026 0.931 . . . . 0.0 111.466 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 126' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' B' ' 187' ' ' ARG . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.463 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -119.96 144.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -134.65 -172.21 2.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.578 2.351 . . . . 0.0 108.796 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -134.15 173.09 11.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.124 0.964 . . . . 0.0 112.685 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -136.36 -14.25 1.74 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.206 1.802 . . . . 0.0 112.855 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -79.28 -53.59 6.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.844 -0.535 . . . . 0.0 110.246 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 18.5 t -70.96 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.216 1.406 . . . . 0.0 109.795 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -127.66 11.15 6.7 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.1 0.96 . . . . 0.0 111.041 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -137.61 174.19 10.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.501 1.12 . . . . 0.0 109.409 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 89.9 p -79.66 158.74 26.95 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.861 1.664 . . . . 0.0 112.265 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.44 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 93.5 mtt-85 -74.31 -18.84 60.65 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.465 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' B' ' 126' ' ' SER . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 193' ' ' PHE . . . . . 0.485 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.5 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo -59.02 120.79 8.88 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 200' ' ' HIS . . . . . 0.457 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 13.5 t60 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 128.679 2.792 . . . . 0.0 113.895 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.1 -2.934 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ' A' . . . . . 0.419 ' N3 ' ' HA2' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.102 2 O4'-C1'-N19 112.324 4.124 OUTLIER-EPSILON 0.68 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ' G' . . . . . 0.421 ' C6 ' ' CG ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.918 1 P-O3'-C3' 126.678 5.815 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ' A' . . . . . 0.708 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.544 2.629 2 O4'-C1'-N19 113.036 4.836 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ' A' . . . . . 0.599 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -2.993 2 O4'-C1'-N19 116.046 7.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ' C' . . . . . 0.599 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C3'-C2'-C1' 104.601 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -146.44 169.9 17.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.275 0.63 . . . . 0.0 110.285 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 32.0 m -140.17 9.98 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.498 0.719 . . . . 0.0 111.034 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.45 19.76 0.07 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -149.71 168.57 23.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.201 0.6 . . . . 0.0 110.082 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -145.07 -20.29 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.42 -173.68 3.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.311 0.645 . . . . 0.0 109.925 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -49.26 107.79 0.84 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.533 1.133 . . . . 0.0 112.047 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.74 9.96 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.113 3.209 . . . . 0.0 112.768 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.48 53.43 3.43 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.84 168.63 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.679 2.253 . . . . 0.0 109.694 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -141.6 -3.32 1.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p -152.74 22.54 0.6 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.297 0.499 . . . . 0.0 111.189 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.413 HD12 ' N ' ' B' ' 120' ' ' LEU . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 124' ' ' GLY . . . . . 0.419 ' HA2' ' N3 ' ' A' ' 2' ' ' ' A' . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' LEU . . . . . 0.413 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' VAL . . . . . 0.438 HG22 " H1'" ' A' ' 5' ' ' ' A' . 65.1 t -84.22 116.52 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' B' ' 158' ' ' SER . 16.2 p90 -171.45 161.68 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.647 0.592 . . . . 0.0 110.195 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -135.61 171.0 15.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.134 0.969 . . . . 0.0 112.437 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.44 -25.71 28.78 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.997 1.719 . . . . 0.0 113.098 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -133.13 -57.42 0.91 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.377 0.671 . . . . 0.0 112.502 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -49.13 102.83 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.853 1.261 . . . . 0.0 110.98 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 39.43 33.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 51.21 179.78 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.59 1.556 . . . . 0.0 112.73 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' B' ' 151' ' ' TYR . 10.1 p -58.17 119.38 6.74 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.791 1.236 . . . . 0.0 111.355 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' ARG . . . . . 0.461 ' HD3' H5'' ' A' ' 4' ' ' ' A' . 89.9 mtt-85 -66.17 -24.54 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.467 0.307 . . . . 0.0 110.199 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 163' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' B' ' 194' ' ' SER . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' MET . . . . . 0.411 ' HG2' HD11 ' B' ' 189' ' ' ILE . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' B' ' 182' ' ' MET . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 194' ' ' SER . . . . . 0.485 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 196' ' ' THR . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 196' ' ' THR . . . . . 0.476 HG23 HG23 ' B' ' 195' ' ' ILE . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 198' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 199' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo -54.66 159.81 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 18.1 t60 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.512 3.125 . . . . 0.0 113.082 -178.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.482 HD12 ' H ' ' B' ' 127' ' ' LEU . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.491 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 . . . . . 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . 0.42 ' CG ' HD11 ' B' ' 189' ' ' ILE . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.42 HD11 ' CG ' ' B' ' 182' ' ' MET . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 195' ' ' ILE . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.503 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo . . . . . 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . 0.446 ' C ' HD12 ' B' ' 120' ' ' LEU . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.446 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.443 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . 0.443 ' H ' HG22 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.529 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.433 ' HA ' ' CA ' ' B' ' 121' ' ' GLY . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.555 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 38.8 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p . . . . . 0 CA--C 1.533 0.311 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . 0.458 ' C ' HD12 ' B' ' 120' ' ' LEU . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.458 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.573 HG22 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' B' ' 161' ' ' PHE . 3.6 m . . . . . 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? . . . . . 0 CA--C 1.531 0.234 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.499 ' CD1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.485 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.464 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo . . . . . 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m . . . . . 0 N--CA 1.454 -0.242 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.41 HG21 HD22 ' B' ' 134' ' ' LEU . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.456 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.41 HD22 HG21 ' B' ' 122' ' ' VAL . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 . . . . . 0 CA--C 1.526 0.046 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 188' ' ' ARG . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.441 HG23 HG23 ' B' ' 196' ' ' THR . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 195' ' ' ILE . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo . . . . . 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m . . . . . 0 CA--C 1.528 0.125 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . 0.437 ' C ' HD12 ' B' ' 120' ' ' LEU . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.437 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . 0.426 HG21 HD22 ' B' ' 134' ' ' LEU . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.522 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . 0.522 ' H ' HG22 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.426 HD22 HG21 ' B' ' 122' ' ' VAL . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.422 HG11 ' CE1' ' B' ' 161' ' ' PHE . 53.8 t . . . . . 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 85.7 mtt-85 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' B' ' 198' ' ' ARG . 73.9 Cg_endo . . . . . 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 119.724 -0.179 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 120' ' ' LEU . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.529 HD22 ' H ' ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . 0.509 HG22 ' CD2' ' B' ' 134' ' ' LEU . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' B' ' 129' ' ' THR . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.441 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.1 mtt-85 . . . . . 0 N--CA 1.461 0.083 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.656 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.656 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo . . . . . 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 C--O 1.232 0.168 0 N-CA-C 110.448 -0.204 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.419 ' H ' HD23 ' B' ' 125' ' ' LEU . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.5 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.476 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t . . . . . 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.3 mtt-85 . . . . . 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 119.702 -0.189 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' B' ' 127' ' ' LEU . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 125' ' ' LEU . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . 0.496 HG22 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . 0.496 ' H ' HG22 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.496 HG13 ' CD1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 50.0 mmt-85 . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.443 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.402 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo . . . . . 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . 0.481 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.51 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p . . . . . 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 84.9 mtt-85 . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.481 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . 0.422 ' HG2' HD11 ' B' ' 189' ' ' ILE . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' B' ' 182' ' ' MET . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.51 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.424 HG23 HG23 ' B' ' 195' ' ' ILE . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo . . . . . 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.462 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.48 ' H ' HD12 ' B' ' 127' ' ' LEU . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . 0.541 HD22 ' H ' ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.445 HG11 ' CE1' ' B' ' 161' ' ' PHE . 7.4 p . . . . . 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 8.5 mmp_? . . . . . 0 N--CA 1.47 0.53 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.469 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.501 HG23 HG23 ' B' ' 196' ' ' THR . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.501 HG23 HG23 ' B' ' 195' ' ' ILE . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.402 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 56.3 Cg_endo . . . . . 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m . . . . . 0 CA--C 1.528 0.124 0 N-CA-C 111.466 0.173 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' B' ' 187' ' ' ARG . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.463 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 93.5 mtt-85 . . . . . 0 C--O 1.228 -0.069 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.465 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' B' ' 126' ' ' SER . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . 0.485 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.5 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo . . . . . 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 120.26 0.076 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.413 ' N ' HD12 ' B' ' 120' ' ' LEU . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' LEU . . . . . 0.413 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' B' ' 161' ' ' PHE . 65.1 t . . . . . 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' B' ' 194' ' ' SER . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' MET . . . . . 0.411 ' HG2' HD11 ' B' ' 189' ' ' ILE . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' B' ' 182' ' ' MET . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' SER . . . . . 0.485 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 196' ' ' THR . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' THR . . . . . 0.476 HG23 HG23 ' B' ' 195' ' ' ILE . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo . . . . . 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.747 0 O4'-C1'-N19 111.738 3.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.258 1 C5'-C4'-C3' 108.885 -4.41 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.427 ' N2 ' HG22 ' B' ' 195' ' ' ILE . . . . . . . . 0 O4'--C4' 1.415 -3.204 1 P-O3'-C3' 124.854 4.295 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.465 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.124 0 O4'-C1'-N19 111.862 3.662 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.481 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -3.009 3 C5'-C4'-C3' 107.212 -5.525 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.481 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.67 0 N19-C1'-C2' 118.912 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 20.4 t-80 -152.21 166.34 32.05 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.116 0.566 . . . . 0.0 109.736 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 28.0 m -144.31 172.51 5.76 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.082 0 C-N-CA 123.399 0.679 . . . . 0.0 110.599 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.71 13.5 0.16 Allowed Glycine 0 CA--C 1.528 0.883 0 N-CA-C 112.036 -0.426 . . . . 0.0 112.036 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -146.53 176.05 10.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.655 0.782 . . . . 0.0 110.845 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 57.0 ttt85 -138.25 -8.24 1.53 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.724 0.81 . . . . 0.0 111.129 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.46 -179.59 8.32 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.974 0.51 . . . . 0.0 110.598 -177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -52.73 113.6 4.71 Favored Pre-proline 0 CA--C 1.536 0.439 0 C-N-CA 124.268 1.027 . . . . 0.0 112.18 -175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -77.27 53.72 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 125.087 3.858 . . . . 0.0 111.586 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -134.3 54.16 11.37 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.1 157.66 53.78 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.155 2.57 . . . . 0.0 110.516 176.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -159.99 -23.99 0.07 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.1 m -144.34 0.09 1.01 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.223 0.609 . . . . 0.0 111.695 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 19.0 p -86.06 73.94 10.18 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.2 mp -67.75 -179.28 1.1 Allowed 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . 177.51 179.28 47.66 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.804 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 4.0 t -129.55 75.67 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.7 m-85 -73.33 135.92 44.39 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -175.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.444 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 56.75 48.94 74.01 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.536 -0.626 . . . . 0.0 111.536 -175.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.482 HD12 ' H ' ' B' ' 127' ' ' LEU . 0.3 OUTLIER -64.05 31.22 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.436 ' H ' ' C ' ' B' ' 124' ' ' GLY . 8.8 m 76.35 -11.54 1.14 Allowed 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 125.937 1.695 . . . . 0.0 112.806 174.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.491 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.3 mp 58.33 21.53 8.38 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.871 1.668 . . . . 0.0 111.408 -176.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -130.26 17.14 5.51 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.783 0.833 . . . . 0.0 111.389 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 66.8 m -136.92 159.06 42.99 Favored 'General case' 0 C--O 1.23 0.072 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 1.4 p -134.43 167.97 19.78 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-O 121.721 0.772 . . . . 0.0 111.904 -177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -16.96 63.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.269 1.028 . . . . 0.0 113.441 -172.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -79.55 -22.22 44.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 122.851 0.46 . . . . 0.0 111.296 175.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -90.92 -38.1 13.1 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 123.057 0.543 . . . . 0.0 110.009 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 96.8 mt -74.17 -23.86 59.3 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 122.564 0.346 . . . . 0.0 110.69 -176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 59.9 ttt85 -71.17 -25.01 62.36 Favored 'General case' 0 C--N 1.339 0.144 0 O-C-N 122.117 -0.365 . . . . 0.0 110.623 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -80.14 -44.33 20.09 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 111.512 0.19 . . . . 0.0 111.512 -177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.67 -25.08 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.107 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -85.03 -27.8 26.14 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t -64.53 -16.06 61.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 122.426 0.29 . . . . 0.0 111.279 176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -73.52 -22.92 59.98 Favored 'General case' 0 C--N 1.341 0.202 0 O-C-N 121.784 -0.572 . . . . 0.0 110.974 178.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -100.74 -8.59 22.6 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.81 177.1 36.35 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.91 154.04 63.38 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.056 2.504 . . . . 0.0 109.842 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -119.8 131.39 72.42 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.056 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -175.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -86.61 -49.79 7.27 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -156.9 172.78 18.04 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.045 0.538 . . . . 0.0 110.348 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.2 p -151.83 152.92 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 42.9 t -152.39 148.34 27.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 122.529 0.332 . . . . 0.0 111.091 -176.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 21.8 mt -135.43 129.93 50.0 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.437 ' HB ' ' H41' ' A' ' 6' ' ' ' C' . 15.0 p -117.27 151.46 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.956 0.884 . . . . 0.0 112.683 -175.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -134.06 -174.63 3.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 127.796 2.439 . . . . 0.0 107.667 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 38.5 t70 -90.21 168.29 12.05 Favored 'General case' 0 CA--C 1.522 -0.096 0 CA-C-O 122.257 1.027 . . . . 0.0 111.149 175.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.468 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 67.6 mt-30 -83.8 -25.52 30.34 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 125.857 1.663 . . . . 0.0 113.203 -176.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -135.69 -61.05 0.73 Allowed 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -172.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 11.8 t -153.25 -154.93 0.56 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.595 0.358 . . . . 0.0 110.931 -170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 57.39 24.44 10.13 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.308 1.043 . . . . 0.0 111.605 -178.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 55.51 178.32 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 125.417 1.487 . . . . 0.0 113.193 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 90.1 p -60.22 143.9 51.47 Favored 'General case' 0 N--CA 1.438 -1.037 0 C-N-CA 125.169 1.388 . . . . 0.0 112.43 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.47 -21.17 61.26 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 169.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 61.9 39.0 96.94 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 124.465 1.031 . . . . 0.0 115.503 167.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.444 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.2 OUTLIER -145.06 170.37 16.31 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 119.102 1.451 . . . . 0.0 112.567 179.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -138.22 168.61 19.39 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -167.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.417 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 7.3 m-85 -133.62 158.86 42.14 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 113.958 -1.474 . . . . 0.0 108.838 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 54.9 t -142.76 149.54 18.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 124.088 0.955 . . . . 0.0 108.565 -178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -135.36 149.76 49.77 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 122.591 0.357 . . . . 0.0 110.191 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -128.97 154.3 46.73 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.332 0.653 . . . . 0.0 109.749 -174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -83.33 -21.31 33.2 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.594 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -142.61 135.94 28.66 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.188 0.995 . . . . 0.0 109.799 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.3 t -99.98 -11.18 8.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -63.59 -7.6 7.62 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.352 0.661 . . . . 0.0 110.566 173.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -136.47 -25.16 1.17 Allowed 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.33 0.652 . . . . 0.0 111.221 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.61 -18.81 65.57 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.505 0.593 . . . . 0.0 111.166 175.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -61.43 -31.89 71.84 Favored 'General case' 0 CA--C 1.528 0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 111.119 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -81.72 -32.35 31.64 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.61 -25.76 67.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.005 0.366 . . . . 0.0 110.491 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -77.97 -49.88 13.24 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -71.32 -27.48 63.43 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.342 -173.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 41.5 mmt180 -84.16 -47.52 10.78 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 122.869 0.468 . . . . 0.0 112.054 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.03 -5.36 58.3 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -172.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -65.98 137.32 57.04 Favored 'General case' 0 N--CA 1.454 -0.256 0 O-C-N 121.548 -0.72 . . . . 0.0 110.062 177.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.91 12.3 28.32 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 119.287 -0.729 . . . . 0.0 113.385 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . 0.42 ' CG ' HD11 ' B' ' 189' ' ' ILE . 27.8 ptm -58.15 160.31 5.1 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.49 1.145 . . . . 0.0 111.026 177.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -86.34 135.33 33.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 64.3 tp -146.87 -31.52 0.33 Allowed 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 123.512 0.725 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -147.58 13.4 1.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.272 1.029 . . . . 0.0 109.135 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 84.54 7.78 84.06 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 123.423 0.535 . . . . 0.0 112.153 -176.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 57.7 mtt-85 -91.94 -10.45 39.4 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 51.31 74.37 0.25 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 121.807 0.813 . . . . 0.0 109.175 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.42 HD11 ' CG ' ' B' ' 182' ' ' MET . 23.0 pt -63.64 167.86 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 125.38 1.472 . . . . 0.0 112.314 -171.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.3 mtp85 -100.75 127.36 47.21 Favored 'General case' 0 C--N 1.334 -0.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 48.8 t -141.41 112.44 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 CA-C-N 118.087 0.403 . . . . 0.0 111.104 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 174.2 -167.07 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.653 1.181 . . . . 0.0 109.865 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -54.82 154.73 4.86 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 117.85 0.296 . . . . 0.0 110.366 175.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' B' ' 195' ' ' ILE . 6.6 t -112.49 -52.29 2.79 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 117.738 -1.125 . . . . 0.0 112.672 -175.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.503 HG12 ' H ' ' B' ' 196' ' ' THR . 12.6 tt 128.42 174.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 129.392 3.077 . . . . 0.0 107.985 -176.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 195' ' ' ILE . 7.7 t 45.96 24.66 0.25 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.947 1.699 . . . . 0.0 114.786 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' B' ' 198' ' ' ARG . 17.5 ptpt 36.39 -76.24 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.729 2.411 . . . . 0.0 115.929 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' B' ' 197' ' ' LYS . 1.3 mpt_? -123.2 169.7 9.6 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-N 119.67 1.123 . . . . 0.0 111.242 -169.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.436 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 33.0 Cg_endo -59.47 156.99 33.34 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.099 2.533 . . . . 0.0 112.607 -177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 8.8 t60 . . . . . 0 C--O 1.249 1.078 0 C-N-CA 129.737 3.215 . . . . 0.0 113.255 179.598 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . 0.424 ' C2 ' ' C5 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.768 0 O4'-C1'-N19 111.099 2.899 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.452 ' C4 ' ' HD2' ' B' ' 190' ' ' ARG . . . . . . . . 0 O4'--C4' 1.411 -3.465 0 O4'-C1'-N19 111.543 3.343 OUTLIER-EPSILON 0.393 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.429 ' N2 ' ' C8 ' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.247 2 O4'-C1'-N19 112.725 4.525 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.48 " H4'" ' HD3' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.851 1 C5'-C4'-C3' 109.097 -4.269 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.496 ' C5 ' ' CZ ' ' B' ' 163' ' ' PHE . . . . . . . . 0 C2'--C1' 1.5 -2.832 3 O4'-C1'-N19 116.946 8.746 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.415 ' H6 ' " O2'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.814 0 N19-C1'-C2' 119.159 3.599 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.758 -0.09 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -142.28 5.8 1.68 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 122.861 0.464 . . . . 0.0 111.541 -178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 27.4 m -144.57 168.66 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 123.494 0.718 . . . . 0.0 109.865 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.46 -173.29 45.32 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -54.84 152.67 7.0 Favored 'General case' 0 CA--C 1.522 -0.107 0 CA-C-O 122.247 1.022 . . . . 0.0 111.089 176.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -75.85 47.57 0.43 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.851 2.06 . . . . 0.0 110.074 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.89 15.45 1.55 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.166 0.987 . . . . 0.0 111.896 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.2 t30 56.87 55.05 7.92 Favored Pre-proline 0 CA--C 1.537 0.474 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 177.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -72.48 10.06 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.243 3.295 . . . . 0.0 112.74 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -147.04 147.26 28.63 Favored Pre-proline 0 CA--C 1.535 0.392 0 O-C-N 121.706 -0.621 . . . . 0.0 109.914 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.19 161.5 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.133 3.222 . . . . 0.0 113.187 176.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -153.49 166.33 33.05 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 72.7 m -135.37 8.09 3.38 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 124.932 1.293 . . . . 0.0 110.387 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . 0.446 ' C ' HD12 ' B' ' 120' ' ' LEU . 72.5 m -136.63 145.31 44.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.446 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.0 mp -119.12 -169.66 1.78 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -177.4 -177.01 45.94 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.393 -0.908 . . . . 0.0 112.485 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 27.1 t -122.9 75.24 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 108.039 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.555 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 2.6 m-85 -75.63 159.51 31.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.876 1.67 . . . . 0.0 108.81 -178.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 130.33 178.18 15.29 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.696 175.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -82.36 26.1 0.57 Allowed 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.531 0.732 . . . . 0.0 110.76 172.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 17.2 p -79.97 62.05 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 122.153 0.978 . . . . 0.0 110.236 174.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 14.8 mt -67.32 27.31 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.065 2.146 . . . . 0.0 114.496 -169.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -136.32 0.94 2.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.172 0.896 . . . . 0.0 112.429 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.3 m -69.7 155.43 40.53 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.382 0.537 . . . . 0.0 110.969 178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.443 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.7 m -144.16 152.6 41.13 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.556 1.142 . . . . 0.0 109.005 -179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -53.8 -32.52 52.93 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.07 0.948 . . . . 0.0 113.181 -175.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . 0.443 ' H ' HG22 ' B' ' 130' ' ' THR . 27.3 mmt85 -68.13 -34.88 77.18 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.118 0.567 . . . . 0.0 111.537 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -70.68 -44.02 67.86 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.035 0.445 . . . . 0.0 110.454 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 95.6 mt -63.2 -32.23 73.57 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.445 0.698 . . . . 0.0 110.937 -177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -63.6 -26.61 68.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.842 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -99.57 -34.27 10.3 Favored 'General case' 0 CA--C 1.516 -0.353 0 O-C-N 122.129 -0.357 . . . . 0.0 111.421 -176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 82.4 t -76.37 -8.11 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.074 -176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -124.42 -28.52 3.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 113.191 0.811 . . . . 0.0 113.191 175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 34.7 t -64.64 -15.34 61.1 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.347 0.976 . . . . 0.0 111.586 178.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -82.12 -28.13 32.4 Favored 'General case' 0 C--N 1.341 0.23 0 O-C-N 121.841 -0.537 . . . . 0.0 111.226 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -87.65 -11.82 47.31 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.13 -178.36 41.34 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.68 164.28 36.01 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.297 2.665 . . . . 0.0 110.546 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 22.7 mm -130.77 140.54 48.47 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.076 0 C-N-CA 123.215 0.606 . . . . 0.0 109.416 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.39 -44.43 9.15 Favored 'General case' 0 C--N 1.34 0.189 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . 0.438 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.5 t0 -164.65 -175.19 3.72 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.726 0.298 . . . . 0.0 111.432 177.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.2 p -148.35 155.21 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.01 0.924 . . . . 0.0 108.814 177.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.2 t -153.42 155.78 36.99 Favored 'General case' 0 C--N 1.334 -0.103 0 C-N-CA 123.306 0.642 . . . . 0.0 110.271 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . 0.42 ' HA ' ' HA ' ' B' ' 162' ' ' ALA . 5.9 mt -137.16 146.66 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 122.01 0.91 . . . . 0.0 111.238 172.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' B' ' 161' ' ' PHE . 7.2 p -125.89 64.77 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 C-N-CA 127.786 2.434 . . . . 0.0 105.095 176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.413 ' O ' ' HB3' ' B' ' 158' ' ' SER . 0.1 OUTLIER -62.63 173.1 1.36 Allowed 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 119.467 3.136 . . . . 0.0 119.467 -164.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -69.4 152.32 45.07 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -80.48 5.62 14.67 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 127.791 2.436 . . . . 0.0 113.069 -174.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.52 -56.99 14.99 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.622 0.725 . . . . 0.0 110.279 -176.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 20.2 t -157.3 21.36 0.3 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 114.396 -1.274 . . . . 0.0 110.018 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -134.21 29.38 3.69 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.45 0.7 . . . . 0.0 112.651 -171.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 51.2 -149.71 0.3 Allowed 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 121.403 0.62 . . . . 0.0 112.547 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' B' ' 151' ' ' TYR . 16.0 t 46.58 -136.43 0.78 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 127.09 2.156 . . . . 0.0 113.454 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.48 ' HD3' " H4'" ' A' ' 4' ' ' ' A' . 11.1 mmp_? -127.14 -57.83 1.3 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 119.626 1.103 . . . . 0.0 113.933 -169.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.88 8.98 0.09 OUTLIER Glycine 0 CA--C 1.532 1.136 0 N-CA-C 116.061 1.184 . . . . 0.0 116.061 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.529 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 48.5 p90 -139.85 -166.99 2.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 119.64 1.72 . . . . 0.0 112.598 -175.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' B' ' 149' ' ' ILE . . . -148.95 178.01 9.06 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 123.625 0.77 . . . . 0.0 113.03 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.496 ' CZ ' ' C5 ' ' A' ' 5' ' ' ' A' . 5.0 m-85 -141.56 158.99 43.13 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.046 176.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 49.7 t -142.36 122.78 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.438 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -91.57 148.74 22.07 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -131.51 166.02 22.29 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.168 0.508 . . . . 0.0 110.854 -178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.13 1.94 4.26 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.235 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -144.73 52.76 1.23 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.25 1.02 . . . . 0.0 109.472 -177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.551 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 78.5 t -52.45 -20.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 C-N-CA 123.511 0.725 . . . . 0.0 111.796 178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -60.96 -13.89 19.08 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.715 0.406 . . . . 0.0 111.114 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -137.56 -18.75 1.24 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.74 0.816 . . . . 0.0 111.545 176.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.66 -14.46 63.03 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 118.805 0.73 . . . . 0.0 110.702 175.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 14.9 ptmm? -63.66 -24.69 67.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 122.235 -0.291 . . . . 0.0 111.231 174.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -73.65 -36.69 65.43 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.21 -20.12 65.65 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.247 -0.283 . . . . 0.0 110.579 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -75.68 -53.76 8.04 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -72.96 -25.95 61.19 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.876 -171.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -77.12 -47.88 19.25 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.962 0.505 . . . . 0.0 111.327 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.16 -4.74 54.23 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -74.52 143.96 44.31 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.521 -0.737 . . . . 0.0 111.143 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.43 -6.08 3.63 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.803 173.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.8 ptm -67.83 162.77 23.31 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.797 1.298 . . . . 0.0 112.007 -178.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -92.42 123.23 35.59 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 173.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 6.5 tt -140.74 -12.64 0.99 Allowed 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -173.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -144.41 3.48 1.16 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.127 0.571 . . . . 0.0 111.132 -175.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.06 6.0 65.44 Favored Glycine 0 CA--C 1.529 0.962 0 CA-C-O 119.452 -0.638 . . . . 0.0 112.689 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -136.36 -2.25 2.26 Favored 'General case' 0 C--N 1.34 0.163 0 CA-C-N 118.13 0.965 . . . . 0.0 112.071 -176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.412 ' N ' ' HD2' ' B' ' 188' ' ' ARG . 2.6 mpt_? 66.72 167.99 0.23 Allowed 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.566 1.546 . . . . 0.0 110.302 -173.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 13.0 pt -140.25 176.64 5.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 122.558 0.343 . . . . 0.0 111.346 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . 0.452 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 46.8 mtp180 -133.52 136.87 45.31 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 175.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -136.32 120.77 25.45 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 CA-C-O 120.555 0.217 . . . . 0.0 110.529 -173.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.3 t0 -173.0 178.96 2.39 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.64 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -49.71 141.78 9.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 169.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.555 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 78.1 p -81.88 -5.09 57.96 Favored 'General case' 0 C--O 1.227 -0.102 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 -171.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 17.1 mt 74.18 -37.99 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 125.468 1.507 . . . . 0.0 113.164 178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.405 HG23 ' N7 ' ' A' ' 4' ' ' ' A' . 15.2 p -91.14 -6.31 53.8 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 118.38 0.536 . . . . 0.0 111.229 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 64.72 -23.73 0.08 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 126.273 1.829 . . . . 0.0 114.746 175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.1 mtm-85 -168.88 173.8 2.34 Favored Pre-proline 0 CA--C 1.533 0.302 0 C-N-CA 124.538 1.135 . . . . 0.0 109.128 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 38.8 Cg_endo -61.61 157.98 39.24 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.589 2.193 . . . . 0.0 112.297 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 11.5 t60 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 129.346 3.059 . . . . 0.0 113.493 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.698 0 O4'-C1'-N19 111.805 3.605 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.412 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.412 -3.423 0 C4'-C3'-C2' 98.752 -3.948 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.412 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.068 1 P-O3'-C3' 126.425 5.605 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.456 " H4'" ' CD ' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.419 -2.838 0 C5'-C4'-C3' 109.886 -3.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.695 ' H62' HG23 ' B' ' 196' ' ' THR . . . . . . . . 0 C2'--C1' 1.502 -2.561 3 O4'-C1'-N19 116.962 8.762 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.607 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.774 0 C3'-C2'-C1' 104.428 3.254 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 . . . . . 0 N--CA 1.477 0.897 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -144.02 23.94 1.67 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.566 0.747 . . . . 0.0 110.932 -175.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.1 m -133.14 17.48 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.526 0.731 . . . . 0.0 111.272 -176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.91 176.12 40.74 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -152.13 168.44 25.28 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.074 0.549 . . . . 0.0 109.872 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 35.7 ptt-85 -154.92 159.88 40.75 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.753 0.421 . . . . 0.0 110.434 -177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.17 -85.48 0.06 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.035 0.534 . . . . 0.0 109.721 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.762 ' H ' ' HD2' ' B' ' 114' ' ' PRO . 60.1 t30 -165.53 -43.24 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.762 ' HD2' ' H ' ' B' ' 113' ' ' ASN . 90.0 Cg_endo -76.92 169.45 21.64 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.214 1.943 . . . . 0.0 112.981 -170.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.466 ' HB2' ' H ' ' B' ' 195' ' ' ILE . 17.2 t70 -152.28 140.87 13.77 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 124.2 1.0 . . . . 0.0 108.772 177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.18 6.93 2.75 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.675 2.917 . . . . 0.0 114.786 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -144.24 174.01 11.26 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 123.192 0.597 . . . . 0.0 112.135 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.3 p -71.57 42.04 0.08 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.115 1.766 . . . . 0.0 112.645 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . 0.458 ' C ' HD12 ' B' ' 120' ' ' LEU . 60.7 m -110.07 111.99 23.71 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.458 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.2 mp -122.24 -167.49 1.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -177.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 166.05 -169.98 40.54 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.36 176.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.48 120.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.462 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 2.9 m-85 -127.02 155.6 42.95 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -169.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.504 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 120.34 -172.9 15.13 Favored Glycine 0 N--CA 1.444 -0.803 0 CA-C-O 121.62 0.567 . . . . 0.0 112.619 175.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.86 19.13 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.859 1.264 . . . . 0.0 112.024 173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.504 ' H ' ' C ' ' B' ' 124' ' ' GLY . 13.9 m -73.5 38.9 0.1 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.107 1.763 . . . . 0.0 112.029 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 9.5 mp -58.63 11.56 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 117.076 2.25 . . . . 0.0 117.076 -169.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -127.14 6.47 6.48 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.468 1.485 . . . . 0.0 112.519 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 96.5 m -63.47 156.12 27.16 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.1 0.56 . . . . 0.0 110.428 172.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.573 HG22 ' H ' ' B' ' 132' ' ' ARG . 47.5 m -141.32 148.82 40.35 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.231 1.012 . . . . 0.0 108.319 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -56.24 -24.99 46.08 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.62 0.768 . . . . 0.0 112.498 -177.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . 0.573 ' H ' HG22 ' B' ' 130' ' ' THR . 72.0 mtm180 -65.34 -34.51 78.5 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 122.856 0.462 . . . . 0.0 111.095 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.82 -54.14 11.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 176.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 mp -59.27 -37.62 78.08 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 124.845 1.258 . . . . 0.0 112.424 -176.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -65.72 -45.66 81.88 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.995 0.426 . . . . 0.0 110.5 -177.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -86.98 -41.27 14.04 Favored 'General case' 0 CA--C 1.512 -0.507 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -169.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.408 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 85.0 t -75.87 -24.73 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.441 -174.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -84.89 -30.09 24.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.5 t -61.87 -18.13 58.99 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 122.56 0.344 . . . . 0.0 111.407 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . 0.408 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.8 mtmt -73.3 -16.5 61.38 Favored 'General case' 0 C--N 1.344 0.331 0 O-C-N 121.725 -0.609 . . . . 0.0 111.555 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -111.36 -4.42 14.91 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.72 176.73 35.09 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.83 159.97 50.89 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 123.037 2.491 . . . . 0.0 110.084 178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 24.5 mm -123.21 142.87 38.22 Favored 'Isoleucine or valine' 0 C--O 1.231 0.11 0 C-N-CA 123.118 0.567 . . . . 0.0 109.519 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -96.07 -48.32 5.72 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -157.43 172.85 17.84 Favored 'General case' 0 CA--C 1.528 0.114 0 C-N-CA 122.975 0.51 . . . . 0.0 111.02 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 p -152.11 155.02 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.09 0.956 . . . . 0.0 108.501 177.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 30.8 t -155.87 153.63 30.01 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.837 0.455 . . . . 0.0 110.676 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 14.0 mt -137.06 136.45 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.825 0.821 . . . . 0.0 109.272 170.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.499 HG23 ' CD1' ' B' ' 161' ' ' PHE . 3.6 m -123.1 55.61 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 128.662 2.785 . . . . 0.0 105.82 -178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -58.66 -169.63 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.961 2.505 . . . . 0.0 116.976 -169.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.414 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 25.1 t70 -45.7 165.7 0.02 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -174.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.414 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 11.5 pt20 -127.8 16.07 6.9 Favored 'General case' 0 N--CA 1.435 -1.176 0 C-N-CA 127.148 2.179 . . . . 0.0 114.166 -168.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . 0.418 ' C ' ' H ' ' B' ' 156' ' ' ARG . 55.3 mt-30 -57.2 -51.82 67.79 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 119.226 0.921 . . . . 0.0 109.741 174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 40.8 m -69.81 15.19 0.08 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.177 1.391 . . . . 0.0 112.058 173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' B' ' 154' ' ' GLN . 88.4 mmt-85 58.76 18.27 5.86 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.335 1.454 . . . . 0.0 113.199 -176.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -83.49 -175.17 5.69 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.806 0.842 . . . . 0.0 110.338 174.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' B' ' 151' ' ' TYR . 16.1 m 4.66 -125.84 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 130.966 3.706 . . . . 0.0 116.54 175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.456 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 4.6 mmp_? -141.72 -68.22 0.38 Allowed 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.583 -0.698 . . . . 0.0 112.172 -175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 156.46 12.06 0.05 OUTLIER Glycine 0 CA--C 1.533 1.18 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.84 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.499 ' CD1' HG23 ' B' ' 150' ' ' VAL . 0.1 OUTLIER -141.75 -163.1 1.51 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.251 1.526 . . . . 0.0 112.067 -170.785 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -154.3 172.66 17.31 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -170.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.485 ' HA ' ' HA3' ' B' ' 121' ' ' GLY . 94.2 m-85 -139.7 155.05 47.58 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.155 176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.88 146.07 23.36 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.054 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -131.54 146.86 52.43 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -174.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -126.69 172.95 9.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.361 0.664 . . . . 0.0 110.303 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.9 -1.08 3.36 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.795 0.438 . . . . 0.0 111.813 -178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -142.3 52.39 1.46 Allowed 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 123.895 0.878 . . . . 0.0 110.321 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.5 p -52.44 -20.23 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 123.734 0.813 . . . . 0.0 112.588 178.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -58.73 -14.9 9.76 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.435 0.694 . . . . 0.0 110.949 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -142.43 -16.7 0.73 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.887 0.475 . . . . 0.0 112.001 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.14 -9.67 56.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 118.711 0.687 . . . . 0.0 111.228 175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -59.02 -24.4 62.78 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 122.174 -0.329 . . . . 0.0 110.911 172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -73.82 -34.39 64.56 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 175.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.09 -25.42 68.09 Favored 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.223 -0.298 . . . . 0.0 110.668 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -76.44 -49.95 15.34 Favored 'General case' 0 CA--C 1.515 -0.369 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -72.23 -26.08 61.89 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.211 -173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 86.8 mmt-85 -82.85 -47.76 11.51 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 122.981 0.512 . . . . 0.0 112.157 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.41 -8.14 59.41 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -173.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -65.08 139.5 58.72 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 118.874 0.761 . . . . 0.0 110.829 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.59 9.42 18.39 Favored Glycine 0 CA--C 1.526 0.731 0 CA-C-O 119.253 -0.748 . . . . 0.0 113.592 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.2 ptm -59.49 157.54 11.21 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.666 1.233 . . . . 0.0 110.883 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.52 129.07 34.29 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 56.8 tp -151.58 -30.57 0.17 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.986 -176.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -144.27 20.37 1.73 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.72 27.57 70.17 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 -176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -125.23 -2.81 7.54 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -171.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.75 68.71 0.73 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 122.089 0.947 . . . . 0.0 109.084 -177.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -60.74 164.08 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 126.625 1.97 . . . . 0.0 113.517 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -88.5 138.99 30.94 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 171.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 20.6 t -143.92 101.51 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.145 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 174.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -169.46 -175.89 2.32 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 110.466 -0.198 . . . . 0.0 110.466 -173.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -44.41 147.06 0.61 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.327 0.651 . . . . 0.0 109.874 171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 79.5 p -103.6 -3.51 25.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -168.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.466 ' H ' ' HB2' ' B' ' 115' ' ' ASP . 12.7 mt 67.76 -3.69 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 119.716 1.144 . . . . 0.0 112.078 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.695 HG23 ' H62' ' A' ' 5' ' ' ' A' . 0.6 OUTLIER -147.28 128.7 14.93 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.034 -1.042 . . . . 0.0 109.544 179.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -74.59 -22.35 59.01 Favored 'General case' 0 C--N 1.338 0.075 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -169.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.464 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 5.0 ptt180 -169.25 172.61 2.73 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 119.292 0.951 . . . . 0.0 110.826 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.2 Cg_endo -55.91 125.9 20.62 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.018 2.478 . . . . 0.0 112.6 177.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . 0.437 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 18.0 t60 . . . . . 0 C--O 1.252 1.194 0 C-N-CA 128.505 2.722 . . . . 0.0 114.008 169.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.891 0 C5'-C4'-C3' 111.277 -2.815 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.422 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.415 -3.176 1 C5'-C4'-C3' 109.45 -4.033 OUTLIER-EPSILON 0.642 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.422 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 P-O3'-C3' 126.827 5.939 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.447 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.411 -3.497 0 P-O3'-C3' 124.145 3.704 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.601 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.502 -2.609 2 O4'-C1'-N19 115.475 7.275 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.601 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.692 0 C3'-C2'-C1' 104.229 3.032 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . 0.406 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 4.1 t60 -152.18 175.94 12.08 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.192 0.597 . . . . 0.0 109.866 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.406 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 34.6 m -138.11 18.69 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 123.729 0.812 . . . . 0.0 111.223 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.09 20.32 3.21 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 111.652 -0.579 . . . . 0.0 111.652 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -62.33 166.17 5.28 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.582 0.706 . . . . 0.0 111.573 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -141.6 2.24 1.6 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.26 1.024 . . . . 0.0 110.709 -177.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -155.94 -176.3 5.88 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.272 1.029 . . . . 0.0 109.433 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -143.16 126.34 9.09 Favored Pre-proline 0 CA--C 1.532 0.266 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -69.61 153.26 69.82 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.086 2.524 . . . . 0.0 111.867 -175.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -163.05 147.67 9.17 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -49.05 134.62 29.72 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.661 2.241 . . . . 0.0 111.718 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' B' ' 193' ' ' PHE . 9.2 p30 -151.43 -173.02 4.38 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.733 0.813 . . . . 0.0 110.702 -174.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.5 m -133.13 23.34 4.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.686 0.794 . . . . 0.0 110.015 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 72.7 m -133.82 95.05 3.38 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.18 0.514 . . . . 0.0 109.614 -177.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.6 mp -74.55 -167.12 0.51 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 173.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.433 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -176.46 -179.66 47.02 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 119.582 -1.294 . . . . 0.0 112.387 176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.41 HG21 HD22 ' B' ' 134' ' ' LEU . 21.8 t -126.25 121.52 59.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.5 m-85 -129.22 147.67 51.09 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -169.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 137.18 -175.98 20.79 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-O 121.672 0.595 . . . . 0.0 113.329 177.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 29.3 mt -77.74 23.05 0.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.404 1.082 . . . . 0.0 110.497 173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 124' ' ' GLY . 78.7 p -82.98 40.54 0.7 Allowed 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.05 0.94 . . . . 0.0 112.298 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.456 ' HG ' ' HA3' ' B' ' 160' ' ' GLY . 10.7 mp -51.47 -17.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.466 1.906 . . . . 0.0 114.137 -174.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -76.11 -15.92 59.99 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.718 0.69 . . . . 0.0 112.017 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 40.7 m -76.55 161.29 28.72 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.306 0.643 . . . . 0.0 111.255 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 15.2 t -151.11 163.29 39.15 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.639 0.776 . . . . 0.0 110.602 177.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -54.93 -33.39 62.17 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.014 0.926 . . . . 0.0 113.133 -177.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -72.15 -30.62 65.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 122.83 0.452 . . . . 0.0 111.179 -176.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.64 -42.3 35.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.268 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.41 HD22 HG21 ' B' ' 122' ' ' VAL . 61.8 mt -67.0 -35.7 80.54 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 123.483 0.713 . . . . 0.0 111.49 -175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.25 65.61 Favored 'General case' 0 CA--C 1.52 -0.178 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.824 -174.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -75.52 -55.97 5.16 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-O 121.027 0.441 . . . . 0.0 110.859 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.42 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 89.6 t -69.73 -31.85 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.607 -171.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -82.54 -27.85 31.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.14 0.427 . . . . 0.0 110.566 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 47.8 t -64.77 -13.9 56.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.841 0.291 . . . . 0.0 111.474 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . 0.42 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 48.5 mtmt -78.41 -30.92 48.0 Favored 'General case' 0 C--N 1.341 0.214 0 O-C-N 121.606 -0.684 . . . . 0.0 111.283 178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -88.07 -10.3 50.63 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.19 -179.66 40.7 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.781 -0.927 . . . . 0.0 110.781 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.55 162.27 43.06 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.213 2.609 . . . . 0.0 110.176 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.1 mm -128.62 150.65 34.49 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.56 -41.12 4.41 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . 0.445 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 0.9 OUTLIER -167.26 -174.85 2.73 Favored 'General case' 0 CA--C 1.527 0.06 0 CA-C-O 121.062 0.458 . . . . 0.0 111.131 176.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.92 153.23 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.077 0.951 . . . . 0.0 108.607 175.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 46.0 t -146.53 148.56 32.3 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.188 0.595 . . . . 0.0 109.864 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 32.2 mt -136.06 129.08 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 7.0 p -120.65 142.01 38.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-O 121.563 0.697 . . . . 0.0 111.858 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -174.74 170.13 3.43 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.928 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 26.3 t70 -71.52 168.82 16.77 Favored 'General case' 0 N--CA 1.457 -0.099 0 CA-C-O 122.168 0.985 . . . . 0.0 112.101 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.411 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 54.1 mt-30 -92.79 -9.17 41.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 126.576 1.951 . . . . 0.0 114.81 -171.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -80.52 -68.98 0.63 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 119.026 0.83 . . . . 0.0 112.399 -172.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.44 ' C ' ' H ' ' B' ' 157' ' ' ARG . 85.3 p -154.59 -158.48 0.86 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.998 -173.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -63.27 9.05 0.06 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 124.249 1.02 . . . . 0.0 112.553 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.44 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.4 mtt85 -62.33 -18.67 62.02 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.735 1.614 . . . . 0.0 111.945 170.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 24.7 p -33.59 135.5 0.12 Allowed 'General case' 0 N--CA 1.435 -1.214 0 C-N-CA 130.659 3.583 . . . . 0.0 113.715 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.441 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.4 mtt-85 -60.03 -25.08 65.03 Favored 'General case' 0 C--N 1.342 0.274 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 174.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' B' ' 127' ' ' LEU . . . 63.52 32.7 85.06 Favored Glycine 0 C--N 1.337 0.589 0 CA-C-O 118.963 -0.909 . . . . 0.0 114.041 169.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 163' ' ' PHE . 0.0 OUTLIER -133.93 169.05 17.67 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 118.795 1.298 . . . . 0.0 111.385 -174.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -147.3 174.69 11.4 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 -163.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.468 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 3.8 m-85 -141.87 158.49 43.72 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.382 175.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 48.1 t -138.0 123.08 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.445 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 4.9 m-30 -91.94 147.93 22.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -176.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -130.25 167.46 18.41 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.389 0.675 . . . . 0.0 110.435 -175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -110.18 -18.07 13.39 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.78 0.324 . . . . 0.0 110.675 -176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.2 m-20 -145.52 141.56 28.4 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.228 1.011 . . . . 0.0 109.118 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.42 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.5 t -107.64 -11.65 10.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -178.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -66.78 -4.15 8.42 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.851 0.46 . . . . 0.0 110.078 171.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -136.19 -28.14 1.06 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.149 0.58 . . . . 0.0 111.056 177.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.42 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.79 -21.73 66.84 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.751 0.705 . . . . 0.0 110.74 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -60.35 -27.4 67.34 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.905 0.482 . . . . 0.0 111.741 178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -77.36 -37.57 51.97 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.0 68.63 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.942 -0.474 . . . . 0.0 110.295 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 28.9 ttmt -73.55 -48.84 29.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -76.84 -27.41 55.12 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.713 -0.676 . . . . 0.0 112.571 -172.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -80.27 -42.75 22.55 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.827 0.285 . . . . 0.0 111.622 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -96.04 9.58 40.33 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -174.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -57.73 -13.06 3.52 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 -175.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -170.3 17.28 0.06 OUTLIER Glycine 0 CA--C 1.525 0.703 0 CA-C-O 119.697 -0.502 . . . . 0.0 113.183 -177.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.4 ptm -65.82 175.14 2.06 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 117.71 0.755 . . . . 0.0 111.794 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -102.28 125.8 49.09 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.2 tt -142.39 -11.0 0.83 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.194 0.598 . . . . 0.0 112.102 -176.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -140.77 4.92 1.94 Allowed 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.223 1.009 . . . . 0.0 110.223 -172.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 74.42 18.19 79.87 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.426 -0.652 . . . . 0.0 112.428 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -139.33 -35.81 0.54 Allowed 'General case' 0 C--N 1.341 0.223 0 CA-C-N 118.156 0.978 . . . . 0.0 111.812 -176.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' B' ' 188' ' ' ARG . 81.3 mmt-85 117.56 162.38 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 129.914 3.285 . . . . 0.0 108.51 174.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 40.2 pt -137.45 173.33 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.238 -178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 23.9 mtp-105 -133.12 131.63 40.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 174.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.5 t -138.14 126.3 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 118.171 0.441 . . . . 0.0 111.375 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -177.1 -177.95 0.78 Allowed 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.82 0.848 . . . . 0.0 109.902 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' B' ' 117' ' ' ASN . 13.6 m-30 -49.44 137.43 14.83 Favored 'General case' 0 N--CA 1.457 -0.108 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 168.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.443 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 61.8 p -62.79 -55.41 26.69 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 117.662 -1.161 . . . . 0.0 112.405 -173.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.441 HG23 HG23 ' B' ' 196' ' ' THR . 10.5 tt 126.14 -6.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 128.81 2.844 . . . . 0.0 110.889 178.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.441 HG23 HG23 ' B' ' 195' ' ' ILE . 39.1 p -125.3 5.94 7.75 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.796 -0.565 . . . . 0.0 111.671 -176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp 68.77 -37.72 0.37 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.468 1.907 . . . . 0.0 113.424 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.502 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 12.8 mtm-85 -173.71 178.46 0.6 Allowed Pre-proline 0 CA--C 1.533 0.326 0 C-N-CA 125.021 1.328 . . . . 0.0 108.943 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 18.6 Cg_endo -56.13 148.55 58.74 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.231 1.954 . . . . 0.0 112.629 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . 0.43 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 11.4 t60 . . . . . 0 C--O 1.251 1.137 0 C-N-CA 128.698 2.799 . . . . 0.0 113.048 175.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.955 0 O4'-C1'-N19 111.07 2.87 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.453 ' N3 ' ' HA3' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.415 -3.153 0 C5'-C4'-C3' 110.6 -3.266 OUTLIER-EPSILON 0.599 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.421 ' OP1' " C1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.412 -3.382 1 P-O3'-C3' 126.577 5.731 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.403 ' N3 ' " C5'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.425 -2.333 2 C5'-C4'-C3' 109.148 -4.235 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.629 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.503 -2.546 4 O4'-C1'-N19 114.959 6.759 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.629 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.543 2.521 0 C3'-C2'-C1' 104.403 3.226 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -62.17 -5.54 2.38 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 14.9 p -152.92 156.11 5.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 123.632 0.773 . . . . 0.0 109.264 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.52 48.44 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.879 -0.889 . . . . 0.0 110.879 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -149.88 172.72 14.72 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.355 0.597 . . . . 0.0 110.855 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -149.35 6.24 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.526 -174.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -152.55 -174.56 4.95 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.936 0.894 . . . . 0.0 109.648 -174.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.554 ' H ' ' HD3' ' B' ' 114' ' ' PRO . 80.1 m-20 -124.27 5.63 0.06 OUTLIER Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' B' ' 113' ' ' ASN . 84.3 Cg_exo -49.86 165.91 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.368 2.045 . . . . 0.0 113.945 171.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -140.27 57.98 9.85 Favored Pre-proline 0 CA--C 1.533 0.308 0 C-N-CA 123.566 0.746 . . . . 0.0 110.57 -177.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.94 158.42 56.72 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.03 2.487 . . . . 0.0 111.051 -177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -150.29 4.57 0.53 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.2 0.6 . . . . 0.0 110.882 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 76.8 m -138.95 16.28 2.65 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 123.637 0.775 . . . . 0.0 110.589 -176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . 0.437 ' C ' HD12 ' B' ' 120' ' ' LEU . 43.0 m -135.97 122.02 20.16 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -175.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.437 HD12 ' C ' ' B' ' 119' ' ' CYS . 8.3 mp -124.61 -170.2 2.11 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.264 1.026 . . . . 0.0 108.677 -175.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 178.1 -179.92 48.32 Favored Glycine 0 N--CA 1.45 -0.403 0 O-C-N 121.853 -0.529 . . . . 0.0 112.482 176.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . 0.426 HG21 HD22 ' B' ' 134' ' ' LEU . 21.2 t -119.71 69.99 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.54 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 53.5 m-85 -70.91 166.27 21.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 113.565 -1.652 . . . . 0.0 112.257 -174.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.453 ' HA3' ' N3 ' ' A' ' 2' ' ' ' A' . . . 90.67 167.99 41.97 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.211 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 79.3 mt -62.93 101.17 0.25 Allowed 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.044 0.537 . . . . 0.0 110.536 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 69.8 m -143.2 41.59 1.51 Allowed 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.422 1.089 . . . . 0.0 109.667 -176.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 7.2 mp -59.49 16.01 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 127.235 2.214 . . . . 0.0 115.112 -173.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 34.0 m-85 -124.82 6.78 8.08 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 119.453 1.024 . . . . 0.0 111.745 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 38.4 m -90.6 160.88 15.69 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.074 0.55 . . . . 0.0 109.956 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.522 HG22 ' H ' ' B' ' 132' ' ' ARG . 22.8 m -140.98 148.52 40.46 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.239 1.015 . . . . 0.0 108.616 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -52.79 -32.75 45.47 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.018 0.927 . . . . 0.0 112.829 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . 0.522 ' H ' HG22 ' B' ' 130' ' ' THR . 99.3 mtt180 -66.95 -34.96 78.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.353 0.661 . . . . 0.0 111.475 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.47 -41.62 65.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 122.514 0.326 . . . . 0.0 110.298 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.426 HD22 HG21 ' B' ' 122' ' ' VAL . 71.7 mt -67.47 -29.94 69.51 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 123.474 0.71 . . . . 0.0 111.262 -177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -68.09 -36.43 79.79 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.662 -177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -82.03 -46.17 14.31 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -175.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.442 ' HA ' ' HE2' ' B' ' 140' ' ' LYS . 97.6 t -74.48 -19.28 16.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.42 -172.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -93.91 -25.9 17.1 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 43.0 t -63.4 -18.38 63.64 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 173.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' B' ' 137' ' ' VAL . 49.0 mtmt -73.53 -17.15 61.24 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 121.86 -0.525 . . . . 0.0 111.327 177.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -111.89 -8.75 14.09 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.63 177.74 39.78 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 118.639 0.654 . . . . 0.0 111.634 179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.68 150.51 50.65 Favored 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.29 2.66 . . . . 0.0 109.617 177.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 34.2 mm -115.58 147.55 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.041 0 C-N-CA 122.701 0.4 . . . . 0.0 109.927 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.61 -45.31 3.7 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.735 0.414 . . . . 0.0 110.218 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -157.82 173.23 17.12 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.034 0.445 . . . . 0.0 110.216 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.9 p -153.56 154.29 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 C-N-CA 123.899 0.879 . . . . 0.0 108.779 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.3 t -156.31 159.53 38.91 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.918 0.487 . . . . 0.0 110.271 -177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 9.7 mt -139.82 155.85 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 CA-C-O 121.99 0.9 . . . . 0.0 110.699 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.549 HG12 ' H ' ' B' ' 159' ' ' ARG . 53.8 t -129.33 135.95 60.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 125.978 1.711 . . . . 0.0 107.259 174.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.779 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -154.55 158.07 39.25 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -168.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -146.45 171.6 14.79 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.393 1.092 . . . . 0.0 113.172 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -126.37 -31.72 2.75 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 127.018 2.127 . . . . 0.0 112.009 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -155.72 -62.88 0.11 Allowed 'General case' 0 N--CA 1.438 -1.044 0 C-N-CA 123.368 0.667 . . . . 0.0 109.647 178.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 79.9 p -171.33 -20.25 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -82.29 13.03 3.78 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -134.73 -163.65 1.4 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.514 1.126 . . . . 0.0 110.344 -175.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.779 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 0.1 OUTLIER -52.2 -152.38 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.649 2.78 . . . . 0.0 111.629 170.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.549 ' H ' HG12 ' B' ' 150' ' ' VAL . 85.7 mtt-85 -133.13 -88.08 0.42 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 120.372 -1.455 . . . . 0.0 113.57 -168.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.56 41.96 0.05 OUTLIER Glycine 0 CA--C 1.529 0.923 0 C-N-CA 119.054 -1.546 . . . . 0.0 115.936 -176.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 41.0 p90 -146.38 -161.46 1.32 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 118.433 1.116 . . . . 0.0 109.894 -178.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.04 168.93 25.7 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.46 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 47.1 m-85 -128.01 155.46 44.27 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.682 0.793 . . . . 0.0 109.499 173.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 52.6 t -143.88 149.26 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.09 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -134.64 149.56 50.56 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 110.386 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -127.69 171.46 11.67 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.117 0.967 . . . . 0.0 110.449 -172.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -114.17 -6.74 13.04 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-O 120.963 0.411 . . . . 0.0 110.801 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -146.28 135.83 23.08 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.468 173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.472 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.1 t -89.95 -18.16 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.959 -177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -74.62 -4.27 36.14 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -120.81 -23.05 6.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.765 0.426 . . . . 0.0 110.476 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -70.78 -30.82 67.41 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 122.051 -0.406 . . . . 0.0 110.253 176.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -68.52 -28.17 66.76 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.22 0.208 . . . . 0.0 111.466 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.28 -37.33 53.1 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.48 -22.53 65.46 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.318 -0.239 . . . . 0.0 110.756 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . 0.404 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 32.1 ttmt -79.11 -47.27 16.41 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 123.081 0.552 . . . . 0.0 109.667 -178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -78.2 -16.04 58.24 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.242 -171.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.5 mmt-85 -99.48 -46.27 5.54 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.93 -0.24 50.61 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -75.54 143.62 42.35 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.688 0.676 . . . . 0.0 110.954 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.98 -3.14 5.69 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.104 0.859 . . . . 0.0 114.508 174.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.71 178.6 2.04 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.738 1.269 . . . . 0.0 111.749 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -117.63 115.54 25.3 Favored 'General case' 0 N--CA 1.458 -0.051 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 2.5 tt -139.48 -6.98 1.32 Allowed 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.862 0.865 . . . . 0.0 111.57 -172.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -142.72 4.44 1.51 Allowed 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 124.401 1.08 . . . . 0.0 110.859 -171.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.09 11.54 85.47 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.633 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -134.54 -4.66 2.58 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.937 0.869 . . . . 0.0 111.859 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . 0.4 ' HD2' ' N ' ' B' ' 188' ' ' ARG . 2.7 mpt_? 65.68 163.1 0.15 Allowed 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 125.567 1.547 . . . . 0.0 109.018 -168.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 27.7 pt -139.13 170.72 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 CA-C-O 120.903 0.382 . . . . 0.0 111.466 -171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . 0.418 ' HD2' ' C4 ' ' A' ' 2' ' ' ' A' . 32.4 mtp-105 -128.35 129.56 46.44 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 174.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 45.0 t -138.21 116.85 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.102 0 CA-C-N 117.555 0.161 . . . . 0.0 111.397 -171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.404 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 9.8 p-10 -179.47 -164.9 0.07 Allowed 'General case' 0 C--O 1.231 0.103 0 C-N-CA 123.88 0.872 . . . . 0.0 110.604 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -47.56 160.59 0.11 Allowed 'General case' 0 C--N 1.342 0.248 0 CA-C-O 120.942 0.401 . . . . 0.0 111.051 174.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 84.8 p -114.17 -8.21 12.98 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 -167.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 15.0 mt 69.87 -3.27 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 CA-C-N 119.882 1.219 . . . . 0.0 111.587 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.44 ' CG2' ' H62' ' A' ' 5' ' ' ' A' . 2.5 t -142.7 -175.56 4.53 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -136.26 -26.76 1.12 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -172.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.483 ' HG3' ' HD2' ' B' ' 199' ' ' PRO . 0.3 OUTLIER -160.7 172.39 5.92 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.483 ' HD2' ' HG3' ' B' ' 198' ' ' ARG . 73.9 Cg_endo -70.39 155.7 63.29 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.561 2.174 . . . . 0.0 111.968 -171.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . 0.464 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 18.7 t60 . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.625 2.77 . . . . 0.0 113.468 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.933 0 C5'-C4'-C3' 111.202 -2.865 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -2.962 0 C5'-C4'-C3' 110.499 -3.334 OUTLIER-EPSILON 0.474 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.2 1 P-O3'-C3' 124.681 4.151 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.486 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.192 0 O4'-C1'-N19 111.927 3.727 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.62 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.422 -2.594 2 O4'-C1'-N19 116.783 8.583 OUTLIER-DELTA 0.0 OUTLIER '7D dist #a' 0.0 . . . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.62 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.82 0 C3'-C2'-C1' 104.582 3.424 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 N--CA 1.475 0.818 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 56.2 p-80 -147.77 12.39 1.0 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.082 0.553 . . . . 0.0 111.042 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.89 161.76 4.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 C-N-CA 123.078 0.551 . . . . 0.0 109.937 -177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 12.21 0.04 OUTLIER Glycine 0 CA--C 1.53 0.974 0 CA-C-O 119.702 -0.499 . . . . 0.0 112.362 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -151.53 160.93 43.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.903 0.852 . . . . 0.0 110.348 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.6 ttt85 -151.63 4.66 0.43 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.838 0.855 . . . . 0.0 111.886 -173.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.4 177.26 9.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.553 -177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.701 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 58.9 t30 -146.68 -34.8 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.701 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 50.5 Cg_exo -56.22 165.84 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.652 2.235 . . . . 0.0 111.928 173.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.79 144.16 19.79 Favored Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 110.626 -0.139 . . . . 0.0 110.626 177.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -86.34 177.96 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 124.502 3.468 . . . . 0.0 111.595 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 37.8 p30 -133.89 4.28 3.54 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 124.66 1.184 . . . . 0.0 111.188 175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 27.9 p -157.64 20.87 0.28 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.463 0.705 . . . . 0.0 111.41 179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 11.7 m -126.58 81.29 2.0 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 -174.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 120' ' ' LEU . 8.5 mp -76.39 -172.06 2.0 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . 176.51 178.68 46.47 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 119.788 -1.196 . . . . 0.0 111.946 174.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 38.1 t -123.74 119.38 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.401 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 3.8 m-85 -127.28 149.1 50.17 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -170.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.18 176.52 16.45 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.92 -0.657 . . . . 0.0 113.206 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 32.9 mt -77.64 50.0 0.79 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 169.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 49.0 m -108.34 43.99 1.17 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.768 1.627 . . . . 0.0 108.321 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.529 HD22 ' H ' ' B' ' 127' ' ' LEU . 0.6 OUTLIER -55.87 5.13 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.663 2.385 . . . . 0.0 116.351 -167.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -124.13 3.31 8.61 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.995 1.27 . . . . 0.0 113.267 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . 0.509 HG22 ' CD2' ' B' ' 134' ' ' LEU . 3.3 m -66.77 155.83 37.11 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 171.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 16.8 m -140.18 145.72 37.83 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.91 0.884 . . . . 0.0 108.773 -178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -46.26 -32.92 3.34 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.889 1.276 . . . . 0.0 113.722 -173.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -67.15 -32.79 74.13 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 111.683 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.1 -43.81 50.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.11 0.564 . . . . 0.0 110.225 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.509 ' CD2' HG22 ' B' ' 129' ' ' THR . 3.2 mm? -60.9 -31.26 70.76 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 122.121 -0.362 . . . . 0.0 110.027 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -65.16 -23.84 67.22 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 122.226 0.21 . . . . 0.0 111.275 -177.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -103.21 -32.89 9.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.702 -0.624 . . . . 0.0 111.233 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.441 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 94.8 t -75.87 -9.79 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.844 -178.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -123.45 -28.41 3.94 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 37.2 t -66.1 -13.73 60.58 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 119.155 0.889 . . . . 0.0 111.361 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 18.1 ptpt -79.93 -36.54 36.14 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 121.51 -0.744 . . . . 0.0 110.989 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -76.05 -12.51 60.14 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.687 0.395 . . . . 0.0 111.977 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.71 178.51 37.39 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.47 166.01 28.7 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.269 2.646 . . . . 0.0 110.734 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 15.9 mm -133.33 147.04 31.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 C-N-CA 123.396 0.678 . . . . 0.0 109.252 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.59 -50.05 4.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -159.76 172.25 18.03 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.838 0.455 . . . . 0.0 111.107 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 19.7 m -145.46 173.53 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 124.636 1.174 . . . . 0.0 108.706 170.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 47.3 t -157.95 153.24 25.86 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 23.2 mt -135.42 102.57 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.491 HG13 ' CE1' ' B' ' 161' ' ' PHE . 0.1 OUTLIER -80.91 129.46 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 124.482 1.113 . . . . 0.0 111.423 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.416 ' HB3' ' H ' ' B' ' 160' ' ' GLY . 8.3 p90 172.18 -177.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 128.351 2.66 . . . . 0.0 108.133 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -129.36 168.34 16.41 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 122.535 1.159 . . . . 0.0 113.166 175.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -72.97 10.85 0.8 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 127.759 2.424 . . . . 0.0 113.813 -173.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 95.3 mm-40 -66.58 -62.85 1.24 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.59 0.632 . . . . 0.0 111.105 -173.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.464 ' C ' ' H ' ' B' ' 157' ' ' ARG . 23.2 t -172.6 -165.59 0.33 Allowed 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.904 1.282 . . . . 0.0 107.818 -179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.19 7.33 0.2 Allowed 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 123.248 0.619 . . . . 0.0 111.856 175.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' B' ' 155' ' ' SER . 23.0 mtt180 -65.01 -19.98 66.27 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 126.253 1.821 . . . . 0.0 112.277 174.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 p -34.94 134.83 0.22 Allowed 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 129.625 3.17 . . . . 0.0 112.996 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.438 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 84.1 mtt-85 -62.11 -21.97 65.44 Favored 'General case' 0 C--N 1.338 0.084 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 174.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' B' ' 151' ' ' TYR . . . 45.13 45.2 9.9 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 125.472 1.51 . . . . 0.0 114.547 170.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.491 ' CE1' HG13 ' B' ' 150' ' ' VAL . 0.2 OUTLIER -132.53 173.3 11.46 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 118.099 0.949 . . . . 0.0 110.1 177.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -142.9 173.73 11.29 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 114.652 1.352 . . . . 0.0 114.652 -164.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -137.56 158.15 45.01 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.099 -1.41 . . . . 0.0 108.535 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 62.6 t -138.29 141.81 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -123.47 142.48 50.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -176.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -129.34 169.89 14.32 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.239 0.542 . . . . 0.0 111.093 -171.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.3 -2.29 5.02 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.768 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.07 54.59 1.37 Allowed 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.473 1.109 . . . . 0.0 110.055 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.565 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 3.6 p -54.19 -19.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.196 176.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -58.91 -13.57 6.73 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.439 0.696 . . . . 0.0 110.969 175.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -137.55 -20.03 1.19 Allowed 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.385 0.674 . . . . 0.0 111.682 175.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.17 -14.02 62.67 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.767 0.712 . . . . 0.0 111.234 176.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -61.08 -24.55 66.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 122.3 -0.25 . . . . 0.0 110.988 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -74.24 -35.09 63.83 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 175.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.08 -25.13 68.23 Favored 'General case' 0 N--CA 1.456 -0.15 0 O-C-N 121.956 -0.465 . . . . 0.0 110.547 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . 0.419 ' HG3' ' HA ' ' B' ' 192' ' ' ASP . 25.8 ttmt -72.44 -48.17 43.15 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.14 -28.05 63.0 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.413 -174.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -78.29 -43.53 27.76 Favored 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.98 0.512 . . . . 0.0 111.849 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -95.61 8.41 43.48 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -57.29 -12.13 2.21 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.284 1.216 . . . . 0.0 114.284 -175.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.39 12.04 0.06 OUTLIER Glycine 0 CA--C 1.528 0.892 0 CA-C-O 119.408 -0.662 . . . . 0.0 113.781 -175.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.0 ptm -60.02 158.68 10.57 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 118.244 1.022 . . . . 0.0 111.69 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -82.97 113.66 20.71 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 176.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 26.4 tp -150.39 105.74 3.37 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 26.4 t0 110.46 -0.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 C-N-CA 128.413 2.685 . . . . 0.0 108.011 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.36 20.21 72.57 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -135.01 -4.79 2.41 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.727 0.811 . . . . 0.0 112.17 -174.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 63.78 171.09 0.17 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 124.751 1.22 . . . . 0.0 109.257 -169.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 25.8 pt -142.5 179.25 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 122.436 0.294 . . . . 0.0 110.291 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 42.7 mtp-105 -134.57 126.19 28.77 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 69.5 t -138.43 124.07 24.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 C-N-CA 120.875 -0.33 . . . . 0.0 111.88 -173.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.419 ' HA ' ' HG3' ' B' ' 176' ' ' LYS . 11.1 p-10 177.5 -169.59 0.08 Allowed 'General case' 0 C--O 1.232 0.148 0 C-N-CA 124.307 1.043 . . . . 0.0 110.187 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -50.2 137.67 17.57 Favored 'General case' 0 N--CA 1.46 0.073 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.401 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 93.4 p -85.66 3.14 42.28 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -169.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.656 HG22 ' H ' ' B' ' 196' ' ' THR . 10.1 mt 60.75 -173.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -167.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.656 ' H ' HG22 ' B' ' 195' ' ' ILE . 21.0 p 49.94 -152.87 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.689 1.131 . . . . 0.0 109.458 -174.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -143.15 -36.83 0.37 Allowed 'General case' 0 C--O 1.231 0.093 0 CA-C-N 118.785 0.72 . . . . 0.0 111.515 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.472 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 6.5 mtm180 -168.77 177.64 1.17 Allowed Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 124.459 1.104 . . . . 0.0 108.778 -179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 21.1 Cg_endo -57.46 152.86 44.6 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.155 1.903 . . . . 0.0 113.26 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 13.1 t60 . . . . . 0 C--O 1.252 1.236 0 C-N-CA 128.831 2.852 . . . . 0.0 112.957 176.968 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.76 0 O4'-C1'-N19 111.267 3.067 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.095 0 O4'-C1'-N19 111.927 3.727 OUTLIER-EPSILON 0.56 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.099 2 O4'-C1'-N19 112.353 4.153 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.56 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.413 -3.351 0 C4'-C3'-C2' 99.554 -3.146 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.551 ' H62' HG23 ' B' ' 196' ' ' THR . . . . . . . . 0 O4'--C4' 1.426 -2.268 1 O4'-C1'-N19 116.766 8.566 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.422 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.62 0 C3'-C2'-C1' 104.762 3.624 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -154.47 174.35 15.02 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 123.228 0.611 . . . . 0.0 110.379 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.08 160.11 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 122.997 0.519 . . . . 0.0 109.959 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.5 178.43 48.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -152.17 165.35 35.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 -150.55 0.52 0.43 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.82 0.848 . . . . 0.0 111.889 -173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.16 -179.04 0.27 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.302 0.641 . . . . 0.0 111.774 178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.726 ' H ' ' CD ' ' B' ' 114' ' ' PRO . 21.6 t-20 -158.21 -33.31 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -178.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.726 ' CD ' ' H ' ' B' ' 113' ' ' ASN . 65.6 Cg_exo -54.55 -17.19 12.22 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.174 2.583 . . . . 0.0 115.101 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -66.55 123.1 84.8 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 118.361 0.528 . . . . 0.0 110.875 -178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -74.11 155.25 47.36 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.185 2.59 . . . . 0.0 110.244 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -160.81 162.39 32.29 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.637 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 80.9 m -81.29 12.31 3.66 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.251 1.021 . . . . 0.0 110.448 174.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 8.2 m -133.64 105.98 7.14 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -175.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.8 mp -77.21 -170.89 1.86 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 173.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' B' ' 191' ' ' VAL . . . -169.53 172.7 43.68 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.416 -1.073 . . . . 0.0 110.416 173.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 5.0 t -124.02 68.48 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -66.68 131.72 46.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 60.57 50.87 62.81 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 -175.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.419 ' H ' HD23 ' B' ' 125' ' ' LEU . 2.5 pt? -64.23 22.1 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 -176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.423 ' H ' ' C ' ' B' ' 124' ' ' GLY . 10.7 m 82.1 -1.26 1.48 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 125.432 1.493 . . . . 0.0 112.282 176.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.5 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.8 mp 51.73 17.78 0.65 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.514 1.526 . . . . 0.0 112.657 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -133.14 18.73 4.07 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.242 1.017 . . . . 0.0 110.434 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 31.9 m -129.25 164.28 23.81 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 123.757 0.823 . . . . 0.0 109.167 177.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.9 t -142.22 168.64 19.26 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.875 0.47 . . . . 0.0 111.46 -176.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -52.34 -36.4 53.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.429 1.092 . . . . 0.0 112.792 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 77.2 mtp180 -68.06 -33.69 75.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.78 -41.5 26.42 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 93.6 mt -67.18 -31.22 71.47 Favored 'General case' 0 N--CA 1.442 -0.869 0 C-N-CA 123.133 0.573 . . . . 0.0 110.884 -178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 62.2 ttt85 -68.23 -31.49 71.03 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 117.711 0.232 . . . . 0.0 111.166 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.51 -45.11 19.93 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 121.136 -0.225 . . . . 0.0 111.465 -177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 83.7 t -73.03 -26.12 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 C-N-CA 120.565 -0.454 . . . . 0.0 111.091 -174.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -84.67 -28.62 26.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 48.3 t -64.72 -15.58 61.68 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.561 0.344 . . . . 0.0 111.293 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -74.06 -29.51 61.92 Favored 'General case' 0 C--N 1.339 0.143 0 O-C-N 121.756 -0.59 . . . . 0.0 111.011 177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -87.54 -14.75 39.4 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.51 178.79 39.38 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.99 158.71 55.75 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 123.178 2.585 . . . . 0.0 109.986 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 23.1 mm -126.89 147.47 31.79 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.065 0 C-N-CA 123.24 0.616 . . . . 0.0 109.467 -176.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -105.3 -47.21 4.02 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -158.39 171.86 19.4 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 121.102 0.477 . . . . 0.0 110.448 -177.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.9 p -153.53 153.88 8.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 34.3 t -157.3 153.03 26.77 Favored 'General case' 0 C--O 1.226 -0.138 0 O-C-N 122.319 -0.238 . . . . 0.0 110.836 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 74.8 mt -130.98 123.9 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 172.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.476 ' HB ' ' CE1' ' B' ' 161' ' ' PHE . 27.0 t -96.03 119.12 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 123.733 0.813 . . . . 0.0 109.24 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -173.74 170.28 4.02 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.866 176.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.521 ' H ' ' HA ' ' B' ' 158' ' ' SER . 10.4 t70 -134.83 -173.73 3.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.95 0.9 . . . . 0.0 110.578 174.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.457 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 15.7 pt20 -119.27 -18.29 8.65 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.167 1.387 . . . . 0.0 112.735 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 50.2 mm-40 -130.83 -55.14 1.06 Allowed 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.551 0.741 . . . . 0.0 111.374 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 36.7 t -56.3 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.249 1.019 . . . . 0.0 110.341 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 40.41 32.66 0.14 Allowed 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 125.787 1.635 . . . . 0.0 113.492 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 52.72 179.54 0.02 OUTLIER 'General case' 0 C--N 1.342 0.245 0 C-N-CA 125.503 1.521 . . . . 0.0 113.469 -175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.521 ' HA ' ' H ' ' B' ' 152' ' ' ASP . 22.9 p -57.69 127.88 34.24 Favored 'General case' 0 N--CA 1.439 -1.014 0 C-N-CA 124.987 1.315 . . . . 0.0 112.462 -177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.413 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 89.3 mtt-85 -67.5 -22.77 65.43 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 173.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 64.05 46.26 91.73 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-O 119.563 -0.576 . . . . 0.0 113.49 172.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.476 ' CE1' ' HB ' ' B' ' 150' ' ' VAL . 0.0 OUTLIER -149.72 164.63 34.72 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 118.312 1.056 . . . . 0.0 110.65 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.36 177.77 8.59 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -168.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.406 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.4 m-85 -141.05 154.3 45.9 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.079 1.352 . . . . 0.0 108.932 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 22.5 t -139.34 149.76 22.93 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -129.47 139.57 51.55 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -123.92 167.41 14.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.76 0.424 . . . . 0.0 110.068 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.0 -7.82 12.51 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -148.9 127.62 12.5 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 44.1 t -79.37 -18.45 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.296 -176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -76.14 -3.66 37.36 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 122.187 -0.321 . . . . 0.0 110.604 175.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -122.58 -20.4 6.02 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.632 0.373 . . . . 0.0 110.46 171.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -73.44 -30.09 62.98 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.046 -0.409 . . . . 0.0 110.335 176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -65.13 -23.68 67.2 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 122.626 0.37 . . . . 0.0 111.921 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.44 -38.0 56.17 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.302 -0.258 . . . . 0.0 110.302 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -73.53 -23.56 60.02 Favored 'General case' 0 N--CA 1.457 -0.1 0 O-C-N 121.967 -0.458 . . . . 0.0 110.453 177.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . 0.625 ' HE3' ' HA ' ' B' ' 192' ' ' ASP . 0.0 OUTLIER -72.15 -56.97 4.67 Favored 'General case' 0 CA--C 1.512 -0.491 0 C-N-CA 124.681 1.193 . . . . 0.0 108.638 -178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -76.04 -25.88 56.06 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.716 -1.129 . . . . 0.0 112.224 -168.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -89.11 -48.71 7.21 Favored 'General case' 0 CA--C 1.519 -0.229 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -176.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.84 2.68 33.01 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -174.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -56.35 -9.86 0.78 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . -168.43 21.52 0.09 OUTLIER Glycine 0 CA--C 1.524 0.622 0 CA-C-O 119.472 -0.627 . . . . 0.0 111.693 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 25.5 ptm -56.69 159.81 3.7 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.506 0.653 . . . . 0.0 111.237 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -83.56 141.7 31.4 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 61.7 tp -151.33 -32.07 0.16 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.932 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -148.01 12.78 0.98 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.509 175.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 83.81 9.91 82.05 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 -176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -93.72 -11.07 32.28 Favored 'General case' 0 C--N 1.341 0.22 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? 50.13 75.17 0.18 Allowed 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -169.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 24.7 pt -59.57 168.72 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 C-N-CA 125.724 1.61 . . . . 0.0 111.809 -171.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 59.7 mtp85 -105.47 117.11 33.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' B' ' 121' ' ' GLY . 40.4 t -127.66 111.44 24.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.625 ' HA ' ' HE3' ' B' ' 176' ' ' LYS . 4.7 p-10 -172.02 -177.51 1.92 Allowed 'General case' 0 N--CA 1.455 -0.187 0 O-C-N 123.679 0.612 . . . . 0.0 112.217 -177.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -57.09 129.33 41.25 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.547 0.739 . . . . 0.0 110.704 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 68.2 p -67.33 -71.68 0.2 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 20.5 tt 146.72 -17.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 129.553 3.141 . . . . 0.0 109.784 -177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.551 HG23 ' H62' ' A' ' 5' ' ' ' A' . 1.6 t -143.04 167.75 21.35 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.147 0.579 . . . . 0.0 109.645 -172.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -129.56 123.96 32.65 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.509 0.323 . . . . 0.0 110.481 -172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 55.09 162.1 0.06 OUTLIER Pre-proline 0 CA--C 1.529 0.152 0 C-N-CA 126.233 1.813 . . . . 0.0 113.666 -175.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -61.85 156.16 50.33 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.669 2.246 . . . . 0.0 113.236 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 15.5 t60 . . . . . 0 C--O 1.251 1.132 0 C-N-CA 129.056 2.942 . . . . 0.0 113.163 177.284 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.867 0 O4'-C1'-N19 111.369 3.169 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.482 " H1'" ' OP1' ' A' ' 3' ' ' ' G' . . . . . . . . 0 O4'--C4' 1.414 -3.257 0 O4'-C1'-N19 111.978 3.778 OUTLIER-EPSILON 0.649 1t . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.482 ' OP1' " H1'" ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.277 1 P-O3'-C3' 126.696 5.83 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.497 " H4'" ' HD2' ' B' ' 159' ' ' ARG . . . . . . . . 0 O4'--C4' 1.414 -3.246 1 C5'-C4'-C3' 109.375 -4.083 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.594 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -2.958 2 O4'-C1'-N19 115.466 7.266 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.594 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.539 0 C3'-C2'-C1' 104.25 3.055 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 110.572 -0.159 . . . . 0.0 110.572 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 54.4 t60 56.06 22.53 5.99 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.488 1.115 . . . . 0.0 113.81 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.03 10.2 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 O-C-N 121.982 -0.449 . . . . 0.0 111.11 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.59 -177.24 40.52 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -145.32 125.03 13.31 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-O 122.126 0.965 . . . . 0.0 110.488 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.1 tpt85 -55.62 -9.17 0.47 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.05 2.14 . . . . 0.0 113.299 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -137.87 12.89 2.9 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -177.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -158.83 134.04 5.75 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 118.51 0.596 . . . . 0.0 110.899 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -73.78 170.99 18.75 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.71 2.94 . . . . 0.0 111.163 -178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . 0.794 ' H ' ' HD2' ' B' ' 116' ' ' PRO . 38.4 t70 -156.29 -38.35 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 114.001 1.112 . . . . 0.0 114.001 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . 0.794 ' HD2' ' H ' ' B' ' 115' ' ' ASP . 47.9 Cg_endo -82.65 176.54 7.72 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.14 1.893 . . . . 0.0 111.671 -176.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -149.46 4.48 0.6 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.35 0.66 . . . . 0.0 110.934 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 84.6 m -142.8 14.89 1.93 Allowed 'General case' 0 C--N 1.339 0.151 0 C-N-CA 123.916 0.886 . . . . 0.0 111.311 -174.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . 0.405 ' SG ' ' HA ' ' B' ' 197' ' ' LYS . 57.3 m -136.72 124.29 22.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.19 -171.9 2.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' B' ' 163' ' ' PHE . . . 168.93 -173.98 43.47 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.647 175.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 60.3 t -120.65 120.85 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' B' ' 161' ' ' PHE . 3.1 m-85 -123.8 150.12 44.88 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -170.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 130.69 -171.9 20.66 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-O 121.745 0.636 . . . . 0.0 112.863 177.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.403 ' HA ' ' CD1' ' B' ' 127' ' ' LEU . 28.5 mt -79.05 24.85 0.3 Allowed 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.05 0.94 . . . . 0.0 110.878 175.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 124' ' ' GLY . 49.6 m -71.96 38.31 0.07 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.583 1.953 . . . . 0.0 112.164 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.403 ' CD1' ' HA ' ' B' ' 125' ' ' LEU . 10.9 mp -56.93 10.18 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.802 2.441 . . . . 0.0 116.267 -172.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -124.87 6.18 8.04 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.725 1.148 . . . . 0.0 112.052 -176.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 33.2 m -74.38 159.92 31.71 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 173.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . 0.496 HG22 ' H ' ' B' ' 132' ' ' ARG . 40.2 m -139.65 148.07 41.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.99 0.916 . . . . 0.0 108.67 -179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -52.97 -33.85 53.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -177.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . 0.496 ' H ' HG22 ' B' ' 130' ' ' THR . 11.7 mpt_? -67.52 -36.15 80.48 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.118 0.567 . . . . 0.0 110.658 -178.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -68.02 -44.14 77.18 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.332 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 85.9 mt -63.6 -30.05 71.21 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 123.29 0.636 . . . . 0.0 111.102 -176.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -67.18 -23.22 65.74 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 120.97 -0.292 . . . . 0.0 111.215 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -96.09 -34.96 11.52 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 117.977 0.353 . . . . 0.0 111.196 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 94.0 t -79.47 -8.38 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.262 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -122.96 -27.79 4.18 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 32.8 t -66.61 -14.16 62.06 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 119.098 0.863 . . . . 0.0 111.638 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -35.53 40.93 Favored 'General case' 0 C--N 1.34 0.175 0 O-C-N 121.84 -0.538 . . . . 0.0 110.826 178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -82.95 -8.27 59.58 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 167.34 176.64 38.32 Favored Glycine 0 CA--C 1.529 0.929 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.77 158.6 52.79 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.338 2.692 . . . . 0.0 110.19 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.6 mm -123.68 153.48 29.5 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.085 0 C-N-CA 122.826 0.451 . . . . 0.0 109.91 -175.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -121.09 -40.27 2.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 122.898 0.479 . . . . 0.0 110.14 177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -155.68 168.33 27.51 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.987 0.422 . . . . 0.0 110.984 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 10.8 p -154.89 155.34 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.6 t -159.43 157.5 30.3 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 34.6 mt -134.11 102.96 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 168.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.496 HG13 ' CD1' ' B' ' 161' ' ' PHE . 0.2 OUTLIER -79.8 125.13 38.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 124.268 1.027 . . . . 0.0 110.875 -176.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 3.3 p90 165.22 -177.7 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 129.103 2.961 . . . . 0.0 109.017 175.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -130.07 167.86 17.65 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.368 1.08 . . . . 0.0 112.468 173.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -74.19 12.35 0.75 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.357 2.263 . . . . 0.0 113.818 -172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 94.4 mm-40 -69.16 -66.49 0.57 Allowed 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 118.835 0.743 . . . . 0.0 110.651 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . 0.458 ' C ' ' H ' ' B' ' 157' ' ' ARG . 77.1 p -166.78 -163.53 0.57 Allowed 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 124.938 1.295 . . . . 0.0 109.116 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -65.03 7.48 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.576 0.75 . . . . 0.0 112.153 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.458 ' H ' ' C ' ' B' ' 155' ' ' SER . 36.7 mtt180 -64.82 -19.36 65.81 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 125.553 1.541 . . . . 0.0 112.611 175.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 60.1 p -36.33 140.46 0.13 Allowed 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 129.371 3.069 . . . . 0.0 112.73 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.497 ' HD2' " H4'" ' A' ' 4' ' ' ' A' . 50.0 mmt-85 -60.17 -23.49 63.99 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 172.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 65.52 29.0 74.18 Favored Glycine 0 C--N 1.339 0.702 0 C-N-CA 125.007 1.289 . . . . 0.0 115.407 168.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.496 ' CD1' HG13 ' B' ' 150' ' ' VAL . 0.4 OUTLIER -142.15 -176.39 4.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-N 119.135 1.467 . . . . 0.0 112.171 -176.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.3 171.55 14.82 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -166.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.472 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 69.7 m-85 -140.81 153.38 45.78 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.645 -1.161 . . . . 0.0 109.219 178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 56.5 t -139.62 144.03 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -130.52 136.82 49.34 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -117.99 157.01 27.55 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 122.962 0.505 . . . . 0.0 110.151 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -89.68 -19.42 24.86 Favored 'General case' 0 CA--C 1.522 -0.103 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.955 -177.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -144.62 142.12 29.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.297 1.039 . . . . 0.0 109.833 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.444 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 26.2 t -108.79 -13.05 10.77 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.058 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 -176.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -64.78 -3.33 3.2 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.822 0.449 . . . . 0.0 110.271 171.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -140.12 -26.46 0.77 Allowed 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.226 0.611 . . . . 0.0 111.459 177.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.444 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -68.59 -16.43 63.85 Favored 'General case' 0 C--N 1.341 0.231 0 CA-C-N 118.868 0.758 . . . . 0.0 111.833 175.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -59.89 -28.03 67.22 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.146 -0.346 . . . . 0.0 111.087 176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -73.38 -32.64 64.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 177.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.69 -24.83 65.45 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.961 -0.462 . . . . 0.0 110.647 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.21 -48.01 18.73 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -77.08 -21.02 55.01 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.466 -171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -95.41 -47.54 6.24 Favored 'General case' 0 CA--C 1.522 -0.134 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -79.49 -2.94 44.4 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -172.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -71.12 140.49 50.63 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 121.638 -0.664 . . . . 0.0 110.675 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.17 5.78 8.73 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 118.956 -0.914 . . . . 0.0 114.254 177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.7 ptm -61.26 160.15 11.02 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 118.838 1.319 . . . . 0.0 110.949 177.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -81.96 129.97 34.94 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 174.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 49.1 tp -152.04 -30.83 0.16 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.815 -176.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -142.59 16.94 2.01 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 124.555 1.142 . . . . 0.0 108.091 -178.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 66.8 24.7 72.92 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 56.1 mtt85 -121.21 -4.78 9.46 Favored 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -174.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.41 72.93 0.37 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 122.007 0.908 . . . . 0.0 108.573 -176.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 26.2 pt -59.76 172.87 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 127.114 2.166 . . . . 0.0 113.67 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -111.77 129.23 56.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 176.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 40.5 t -143.07 118.03 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 CA-C-N 117.607 0.185 . . . . 0.0 110.894 -176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 177.86 -165.2 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.867 0.867 . . . . 0.0 109.825 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -49.74 144.4 6.28 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.031 0.443 . . . . 0.0 110.518 175.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.402 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 73.8 p -96.32 2.04 52.46 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -169.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . . . . . . . . . 12.2 mt 63.5 7.1 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 119.658 1.117 . . . . 0.0 111.047 -176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 38.9 p -144.18 176.12 9.56 Favored 'General case' 0 N--CA 1.458 -0.06 0 O-C-N 121.231 -0.918 . . . . 0.0 108.524 -176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' B' ' 119' ' ' CYS . 3.9 mppt? -128.91 -18.03 3.86 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -173.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.468 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.2 mtt180 -179.96 172.0 0.56 Allowed Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.163 0.985 . . . . 0.0 109.324 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.468 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 30.6 Cg_endo -59.51 157.16 32.82 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.983 2.456 . . . . 0.0 112.186 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 16.2 t60 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 129.824 3.25 . . . . 0.0 113.106 179.064 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.862 0 C5'-C4'-C3' 111.091 -2.939 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.081 0 O4'-C1'-N19 111.83 3.63 OUTLIER-EPSILON 0.627 1t . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.408 ' C6 ' ' CG ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -2.962 1 P-O3'-C3' 126.59 5.742 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.609 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.007 0 O4'-C1'-N19 111.527 3.327 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.578 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.499 -2.919 2 O4'-C1'-N19 114.489 6.289 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.578 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.88 0 N19-C1'-C2' 118.771 3.357 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.44 0.162 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 55.1 p-80 -152.31 174.2 14.1 Favored 'General case' 0 C--O 1.23 0.047 0 C-N-CA 123.506 0.722 . . . . 0.0 110.066 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.89 -0.84 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 123.186 0.594 . . . . 0.0 111.134 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.1 -23.62 2.08 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -47.94 103.62 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.883 1.273 . . . . 0.0 112.305 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 55.33 26.56 8.79 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.02 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -146.23 16.04 1.33 Allowed 'General case' 0 C--O 1.231 0.129 0 C-N-CA 123.242 0.617 . . . . 0.0 112.035 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.404 ' CG ' ' HD2' ' B' ' 114' ' ' PRO . 10.0 t-20 -157.86 151.92 19.92 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -175.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' B' ' 113' ' ' ASN . 51.0 Cg_endo -65.01 168.02 14.72 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 C-N-CA 123.037 2.491 . . . . 0.0 111.476 176.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -63.49 147.54 95.2 Favored Pre-proline 0 CA--C 1.53 0.2 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -79.49 -168.96 0.7 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 124.86 3.706 . . . . 0.0 110.286 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -140.27 11.29 2.35 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.955 0.502 . . . . 0.0 110.574 177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 77.3 m -138.83 12.1 2.68 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.266 0.626 . . . . 0.0 112.067 -176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . 0.481 ' SG ' ' CE1' ' B' ' 165' ' ' TYR . 41.2 t -141.73 140.81 33.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 7.6 mp -126.12 -171.59 2.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.41 ' HA3' ' CE1' ' B' ' 123' ' ' PHE . . . -178.38 179.03 48.72 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.519 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 13.6 t -129.56 67.67 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 C-N-CA 125.334 1.453 . . . . 0.0 107.093 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.51 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 1.4 m-85 -70.46 157.79 37.21 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 114.499 -1.228 . . . . 0.0 110.151 -176.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.31 -164.83 24.82 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-O 121.539 0.522 . . . . 0.0 112.93 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 52.2 mt -105.16 34.19 3.33 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.978 1.311 . . . . 0.0 108.333 172.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 66.1 m -72.91 39.28 0.09 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.129 1.771 . . . . 0.0 112.405 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.52 -15.61 1.85 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.825 0.85 . . . . 0.0 112.107 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -78.72 4.96 12.32 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.176 0.591 . . . . 0.0 112.545 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 36.8 m -126.55 158.84 35.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 118.525 0.602 . . . . 0.0 110.721 -177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.9 m -138.09 157.27 46.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.407 1.083 . . . . 0.0 109.068 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -48.65 -33.19 9.51 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.733 1.213 . . . . 0.0 113.646 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 95.0 mtm-85 -66.33 -34.36 77.81 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 118.038 0.381 . . . . 0.0 111.878 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.2 -42.76 45.16 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 120.788 0.328 . . . . 0.0 110.231 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 81.1 mt -65.0 -28.56 69.59 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 123.36 0.664 . . . . 0.0 111.031 -178.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 -65.38 -27.65 68.71 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.444 -0.16 . . . . 0.0 110.879 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -94.37 -32.71 13.46 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-O 120.839 0.352 . . . . 0.0 111.751 -176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 90.5 t -79.12 -10.07 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.817 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -113.45 -25.92 8.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 87.4 p -70.81 -12.31 61.47 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 118.329 0.513 . . . . 0.0 111.369 177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -81.54 -27.83 34.22 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.492 0.317 . . . . 0.0 111.247 179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -88.69 -8.48 54.48 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 163.09 -178.53 38.74 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -179.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.58 162.77 41.15 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.227 2.618 . . . . 0.0 110.226 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 27.2 mm -131.37 148.96 32.73 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.58 -44.9 3.96 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -158.58 172.27 18.61 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.213 0.53 . . . . 0.0 110.412 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.8 p -151.89 152.13 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 35.3 t -155.05 150.63 27.48 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.505 -0.122 . . . . 0.0 111.102 -177.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 57.0 mt -133.25 128.37 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.96 144.06 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-O 121.863 0.84 . . . . 0.0 111.096 -175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.454 ' HB2' ' CA ' ' B' ' 158' ' ' SER . 8.1 p90 -168.65 -50.38 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.79 -177.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . 0.562 ' CG ' ' H ' ' B' ' 153' ' ' GLN . 12.0 t70 43.03 -173.19 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 127.436 2.294 . . . . 0.0 115.042 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . 0.562 ' H ' ' CG ' ' B' ' 152' ' ' ASP . 72.7 mt-30 -73.04 21.19 0.07 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 127.857 2.463 . . . . 0.0 112.116 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -55.17 -50.49 69.18 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.309 1.043 . . . . 0.0 111.868 -175.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 54.7 m -132.18 -173.48 3.17 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.52 -1.218 . . . . 0.0 109.276 177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 79.4 mtt85 -65.98 -2.46 4.01 Favored 'General case' 0 N--CA 1.46 0.07 0 C-N-CA 123.4 0.68 . . . . 0.0 112.753 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.9 171.32 18.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.008 1.323 . . . . 0.0 111.307 174.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.454 ' CA ' ' HB2' ' B' ' 151' ' ' TYR . 8.2 p -73.48 147.87 43.7 Favored 'General case' 0 N--CA 1.436 -1.155 0 C-N-CA 126.086 1.754 . . . . 0.0 112.455 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.446 ' HD3' H5'' ' A' ' 4' ' ' ' A' . 84.9 mtt-85 -73.02 -29.8 63.28 Favored 'General case' 0 C--N 1.342 0.26 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 172.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 78.72 22.62 66.27 Favored Glycine 0 CA--C 1.525 0.707 0 CA-C-O 118.625 -1.097 . . . . 0.0 115.484 169.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER -129.65 165.66 21.35 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 119.504 1.652 . . . . 0.0 111.789 -172.284 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -139.96 172.69 12.4 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 -167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.421 ' CE2' ' C5 ' ' A' ' 5' ' ' ' A' . 73.1 m-85 -138.69 156.17 47.63 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 114.341 -1.3 . . . . 0.0 108.888 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.0 151.07 21.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.481 ' CE1' ' SG ' ' B' ' 119' ' ' CYS . 99.1 m-85 -133.42 148.08 51.77 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -129.33 169.45 14.86 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.747 0.819 . . . . 0.0 109.796 -170.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -111.95 -14.86 13.43 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 121.219 0.533 . . . . 0.0 110.861 -176.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -143.32 141.31 30.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.675 1.19 . . . . 0.0 109.065 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.431 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 37.9 t -103.11 -12.53 8.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -177.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -67.16 -3.91 8.87 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 122.933 0.493 . . . . 0.0 110.305 172.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -135.78 -26.02 1.23 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.364 0.665 . . . . 0.0 110.942 178.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -64.35 -26.47 68.49 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 118.613 0.642 . . . . 0.0 110.547 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -64.64 -29.72 70.73 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.661 0.384 . . . . 0.0 111.469 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -82.71 -31.54 28.47 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 122.098 -0.376 . . . . 0.0 110.014 178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.05 -25.66 68.48 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 118.113 0.415 . . . . 0.0 110.152 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -76.47 -50.02 15.12 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -73.43 -21.93 60.34 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.933 -171.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -92.7 -45.95 7.8 Favored 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -86.01 -4.61 59.21 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -69.41 136.06 51.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 118.982 0.81 . . . . 0.0 110.631 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 60.61 8.45 9.79 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-O 118.698 -1.057 . . . . 0.0 114.412 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . 0.422 ' HG2' HD11 ' B' ' 189' ' ' ILE . 27.0 ptm -62.94 152.78 35.59 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 119.369 1.585 . . . . 0.0 110.015 176.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -86.25 101.66 13.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 4.9 tt -133.15 -10.91 2.93 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 123.554 0.742 . . . . 0.0 111.469 -174.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 30.0 p-10 -145.15 6.19 1.13 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.148 0.979 . . . . 0.0 110.775 -176.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 76.02 14.29 82.37 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.488 -0.618 . . . . 0.0 112.65 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.4 mtt-85 -127.57 -6.54 5.76 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 118.127 0.963 . . . . 0.0 112.818 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 61.25 86.03 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.422 HD11 ' HG2' ' B' ' 182' ' ' MET . 25.0 pt -60.59 167.9 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 C-N-CA 125.064 1.346 . . . . 0.0 113.903 -168.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 65.4 mtp85 -111.58 118.03 34.59 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.6 t -138.24 119.48 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.295 0 CA-C-N 118.001 0.364 . . . . 0.0 111.508 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 175.78 -166.72 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.281 1.032 . . . . 0.0 110.179 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -52.64 144.98 12.75 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 120.876 0.369 . . . . 0.0 110.9 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.51 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 63.5 p -78.37 -64.78 1.09 Allowed 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 118.121 -0.942 . . . . 0.0 113.405 -172.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' B' ' 194' ' ' SER . 12.2 tt 128.66 -0.24 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 129.675 3.19 . . . . 0.0 108.822 -174.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.424 HG23 HG23 ' B' ' 195' ' ' ILE . 6.1 p -138.29 178.52 7.07 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 124.258 1.023 . . . . 0.0 110.33 -172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -139.89 97.38 3.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.473 0.709 . . . . 0.0 109.284 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.455 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 22.7 mtm180 60.65 166.0 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 125.447 1.499 . . . . 0.0 113.058 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 24.0 Cg_endo -57.47 157.74 21.54 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.735 2.957 . . . . 0.0 112.634 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 12.3 t60 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 129.575 3.15 . . . . 0.0 113.085 178.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . 0.411 ' C2 ' ' C4 ' ' A' ' 2' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.418 -2.922 0 O4'-C1'-N19 111.04 2.84 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.411 ' C4 ' ' C2 ' ' A' ' 1' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.043 1 O4'-C1'-N19 112.253 4.053 OUTLIER-EPSILON 0.185 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.499 ' C2 ' ' CZ ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.102 1 P-O3'-C3' 125.833 5.111 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.465 ' N3 ' H5'' ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.968 0 C5'-C4'-C3' 110.743 -3.172 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.682 " H1'" ' C5 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.42 -2.787 1 O4'-C1'-N19 116.185 7.985 OUTLIER-DELTA 0.0 OUTLIER delta 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.682 ' C5 ' " H1'" ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.421 -2.667 0 C3'-C2'-C1' 104.997 3.885 . 0.0 OUTLIER delta-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.382 0.134 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -150.98 -178.68 6.74 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.376 0.67 . . . . 0.0 110.094 179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.51 7.2 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.81 0.444 . . . . 0.0 111.533 -178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.27 -13.15 0.1 Allowed Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.851 -0.416 . . . . 0.0 112.244 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -51.83 123.81 11.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.613 0.707 . . . . 0.0 110.776 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 39.34 38.54 0.37 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.105 1.762 . . . . 0.0 114.017 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.23 29.76 1.62 Allowed 'General case' 0 C--N 1.332 -0.154 0 C-N-CA 124.384 1.074 . . . . 0.0 110.939 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 -150.84 69.41 8.49 Favored Pre-proline 0 N--CA 1.449 -0.488 0 C-N-CA 122.265 0.226 . . . . 0.0 111.298 -174.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -71.41 24.96 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 125.176 3.917 . . . . 0.0 112.862 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -136.68 52.04 5.53 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 123.294 0.638 . . . . 0.0 111.018 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.2 170.55 19.59 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 124.017 3.145 . . . . 0.0 111.699 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -155.44 154.76 32.4 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.557 0.743 . . . . 0.0 109.317 177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.05 18.46 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.849 2.06 . . . . 0.0 115.778 -177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 56.6 m -135.09 115.45 13.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 10.4 mp -105.53 178.89 4.43 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' B' ' 163' ' ' PHE . . . -133.64 163.57 24.42 Favored Glycine 0 N--CA 1.442 -0.941 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 18.6 t -135.63 53.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 175.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 161' ' ' PHE . 24.0 m-85 -66.78 169.05 8.55 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 113.473 -1.694 . . . . 0.0 111.047 -176.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.462 ' C ' ' H ' ' B' ' 126' ' ' SER . . . 125.94 162.63 11.34 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 173.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.51 21.59 0.06 Allowed 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.961 0.504 . . . . 0.0 111.385 174.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.462 ' H ' ' C ' ' B' ' 124' ' ' GLY . 16.3 m -81.39 36.88 0.44 Allowed 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.248 1.019 . . . . 0.0 111.982 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.48 ' H ' HD12 ' B' ' 127' ' ' LEU . 7.9 mp -50.94 -17.51 0.59 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.309 1.444 . . . . 0.0 114.095 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -73.89 -10.3 59.52 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -176.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 2.0 m -75.47 164.43 26.37 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.302 0.501 . . . . 0.0 109.785 176.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 17.9 m -137.64 145.84 43.18 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.94 0.896 . . . . 0.0 108.697 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -45.16 -33.1 2.09 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.728 1.211 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -65.08 -37.33 87.15 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 123.09 0.556 . . . . 0.0 111.297 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -70.17 -47.14 62.9 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . 0.541 ' H ' HD22 ' B' ' 134' ' ' LEU . 2.7 mm? -63.46 -31.7 72.93 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 122.193 0.197 . . . . 0.0 111.456 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -69.26 -38.11 78.25 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 121.987 -0.446 . . . . 0.0 111.388 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -78.75 -46.34 19.13 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 86.9 t -71.79 -24.9 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 120.972 -0.291 . . . . 0.0 111.047 -172.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -87.44 -27.36 22.76 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 36.1 t -68.26 -11.16 58.92 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.398 0.279 . . . . 0.0 111.144 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -75.41 -31.01 60.26 Favored 'General case' 0 C--O 1.231 0.127 0 O-C-N 121.759 -0.588 . . . . 0.0 110.76 177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -91.82 -8.73 45.8 Favored 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 166.26 -178.26 40.89 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 161.57 45.41 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 123.197 2.598 . . . . 0.0 110.403 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 36.9 mm -126.58 151.04 32.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.94 -46.03 3.69 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 176.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -153.71 -179.93 8.26 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.037 0.446 . . . . 0.0 110.331 -178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.27 152.54 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 21.2 t -153.06 153.2 32.39 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-O 120.801 0.334 . . . . 0.0 111.421 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 20.7 mt -140.04 141.96 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.632 1.173 . . . . 0.0 107.997 169.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.452 ' HB ' ' H41' ' A' ' 6' ' ' ' C' . 7.4 p -120.78 138.43 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 169.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.67 ' H ' ' HB2' ' B' ' 158' ' ' SER . 0.1 OUTLIER -151.34 -168.25 3.04 Favored 'General case' 0 C--O 1.225 -0.224 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -162.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 35.2 t0 -122.36 173.13 7.83 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 122.078 0.942 . . . . 0.0 112.034 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -134.84 -37.35 0.82 Allowed 'General case' 0 N--CA 1.431 -1.383 0 C-N-CA 126.191 1.796 . . . . 0.0 111.919 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -167.95 -57.14 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.577 0.751 . . . . 0.0 109.063 174.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 48.8 m -154.85 5.13 0.23 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.301 0.64 . . . . 0.0 112.414 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -122.07 38.88 4.02 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.541 1.136 . . . . 0.0 109.825 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -49.66 150.47 2.03 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -173.009 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.67 ' HB2' ' H ' ' B' ' 151' ' ' TYR . 14.0 m -75.01 -32.4 61.61 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.095 2.158 . . . . 0.0 109.252 168.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.43 ' CD ' " H4'" ' A' ' 4' ' ' ' A' . 8.5 mmp_? 158.35 -121.94 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 130.901 3.68 . . . . 0.0 107.094 173.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 174.87 54.2 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 CA-C-N 119.272 0.942 . . . . 0.0 113.34 -178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.664 ' CE2' ' CE2' ' B' ' 123' ' ' PHE . 28.5 p90 -162.4 -170.5 2.46 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 117.789 0.795 . . . . 0.0 109.951 177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -146.61 172.25 13.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 O-C-N 121.063 -1.023 . . . . 0.0 113.743 -177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.469 ' CZ ' ' HE2' ' B' ' 161' ' ' PHE . 75.5 m-85 -139.47 162.68 34.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.409 173.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 78.4 t -141.58 148.21 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 C-N-CA 124.669 1.188 . . . . 0.0 108.003 172.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -130.62 153.14 49.23 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.205 -0.309 . . . . 0.0 110.651 -170.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -132.22 171.84 13.17 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.742 0.417 . . . . 0.0 110.585 -169.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -13.68 9.11 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.513 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -143.57 131.95 22.15 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.473 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -88.64 -13.1 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -65.46 -5.93 9.1 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.128 0.571 . . . . 0.0 110.661 173.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -137.01 -23.6 1.14 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.298 0.639 . . . . 0.0 111.276 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.473 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.6 -24.95 66.4 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.655 0.661 . . . . 0.0 110.628 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -66.57 -28.36 68.46 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.178 0.191 . . . . 0.0 111.353 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -77.59 -38.46 48.18 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.42 -22.01 65.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 122.385 -0.197 . . . . 0.0 110.764 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.8 ttmt -77.48 -48.76 16.28 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.69 -20.16 47.21 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.306 -171.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 88.7 mmt-85 -94.21 -46.98 6.85 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.28 -2.45 48.98 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -173.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -75.42 137.35 40.94 Favored 'General case' 0 N--CA 1.454 -0.265 0 O-C-N 121.711 -0.618 . . . . 0.0 110.078 177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.83 6.02 8.41 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-O 118.852 -0.971 . . . . 0.0 114.383 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 28.3 ptm -60.93 153.37 25.14 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 119.109 1.455 . . . . 0.0 110.203 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -82.4 122.33 27.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 55.2 tp -137.9 -28.32 0.88 Allowed 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.267 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -144.31 12.55 1.56 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.061 0.944 . . . . 0.0 109.109 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 79.08 18.26 75.03 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.434 -0.667 . . . . 0.0 111.434 -175.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -115.75 -8.17 12.04 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -172.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 26.4 mmt85 51.98 79.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 124.405 1.082 . . . . 0.0 110.317 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 16.9 pt -57.02 170.7 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 C-N-CA 126.002 1.721 . . . . 0.0 113.917 -168.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 72.1 mtp85 -118.45 115.78 25.33 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 74.7 t -135.71 120.62 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 C-N-CA 122.253 0.221 . . . . 0.0 111.003 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -179.07 173.76 1.13 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.235 1.014 . . . . 0.0 109.131 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -39.77 130.96 1.9 Allowed 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 117.908 0.322 . . . . 0.0 110.216 175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . . . . . . . . . 63.5 p -61.75 -64.57 0.9 Allowed 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 117.995 -1.002 . . . . 0.0 111.87 -171.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.501 HG23 HG23 ' B' ' 196' ' ' THR . 5.7 tt 120.87 0.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 129.874 3.27 . . . . 0.0 110.879 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.501 HG23 HG23 ' B' ' 195' ' ' ILE . 2.9 p -135.74 7.07 3.23 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 114.136 1.162 . . . . 0.0 114.136 -171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt 35.4 90.79 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 125.721 1.608 . . . . 0.0 114.733 176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.402 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 4.0 mpt_? 62.67 170.72 0.08 OUTLIER Pre-proline 0 N--CA 1.466 0.373 0 C-N-CA 124.22 1.008 . . . . 0.0 111.734 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 56.3 Cg_endo -66.4 163.32 32.72 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 122.174 1.916 . . . . 0.0 113.054 -175.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 7.0 t60 . . . . . 0 C--O 1.251 1.176 0 C-N-CA 127.893 2.477 . . . . 0.0 112.394 178.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.684 0 O4'-C1'-N19 111.699 3.499 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.462 ' N3 ' ' HA3' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.103 1 C5'-C4'-C3' 108.13 -4.914 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.474 ' N2 ' HG22 ' B' ' 195' ' ' ILE . . . . . . . . 0 O4'--C4' 1.416 -3.121 1 P-O3'-C3' 126.868 5.973 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.502 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -2.981 0 C3'-C2'-C1' 104.516 3.351 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.584 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.5 -2.829 3 C5'-C4'-C3' 107.277 -5.482 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.584 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.42 -2.775 0 C3'-C2'-C1' 104.177 2.975 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . 0.525 ' CG ' ' H ' ' B' ' 108' ' ' VAL . 8.7 t-80 -73.07 -177.23 2.37 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.21 0.604 . . . . 0.0 111.18 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.525 ' H ' ' CG ' ' B' ' 107' ' ' HIS . 9.7 p -137.19 12.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.068 0.547 . . . . 0.0 110.954 -176.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -151.34 18.64 0.91 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.889 -0.485 . . . . 0.0 111.889 -178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -48.5 123.0 6.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.46 0.704 . . . . 0.0 111.35 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 ptt180 40.19 30.34 0.07 Allowed 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.488 1.915 . . . . 0.0 115.226 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -145.14 -7.14 0.63 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.598 0.759 . . . . 0.0 111.752 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -162.0 65.57 1.87 Allowed Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 122.529 0.331 . . . . 0.0 110.693 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -51.44 153.27 10.55 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.956 3.104 . . . . 0.0 113.74 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -155.32 163.44 24.56 Favored Pre-proline 0 CA--C 1.532 0.281 0 C-N-CA 124.98 1.312 . . . . 0.0 108.611 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.65 162.37 37.41 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.889 2.393 . . . . 0.0 109.585 173.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -154.07 162.33 41.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.893 0.378 . . . . 0.0 111.672 -173.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 79.6 m -74.33 2.97 8.09 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.026 0.931 . . . . 0.0 111.466 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 62.8 m -137.26 153.85 50.26 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 110.33 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 9.3 mp -114.75 -165.0 0.98 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.415 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -172.89 178.19 45.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.25 175.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.67 77.05 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.522 ' C ' ' H ' ' B' ' 125' ' ' LEU . 4.5 m-85 -75.4 146.62 40.65 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.095 -172.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.465 ' H ' ' HB2' ' B' ' 161' ' ' PHE . . . 62.61 -9.45 0.15 Allowed Glycine 0 CA--C 1.53 1.014 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.17 -171.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' B' ' 123' ' ' PHE . 0.4 OUTLIER 32.63 -140.44 0.01 OUTLIER 'General case' 0 C--N 1.342 0.281 0 C-N-CA 126.506 1.923 . . . . 0.0 112.656 179.005 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . 0.42 ' HA ' ' CD ' ' B' ' 187' ' ' ARG . 31.9 t -135.25 2.76 3.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.258 175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.463 ' N ' HD12 ' B' ' 127' ' ' LEU . 6.9 mp 50.46 15.23 0.2 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.507 1.923 . . . . 0.0 113.211 -175.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -139.22 25.6 2.45 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.071 0.949 . . . . 0.0 110.187 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 25.7 m -134.33 159.59 40.55 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.524 0.73 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 20.1 m -135.7 160.9 37.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.143 0.977 . . . . 0.0 109.282 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -45.81 -34.76 3.92 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.952 1.301 . . . . 0.0 113.744 -177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 86.4 mtm180 -67.27 -35.59 79.82 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -76.42 -42.76 43.01 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.0 110.304 179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 91.0 mt -65.8 -29.8 70.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.215 0.606 . . . . 0.0 110.432 -178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -65.04 -24.08 67.37 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 122.337 -0.227 . . . . 0.0 110.859 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -90.1 -30.87 17.4 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.048 0.451 . . . . 0.0 111.52 -178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . 0.494 ' HA ' ' HE3' ' B' ' 140' ' ' LYS . 92.1 t -78.64 -13.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.662 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -110.79 -24.01 10.7 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 99.1 p -70.14 -10.98 60.5 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 118.173 0.442 . . . . 0.0 112.106 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' B' ' 137' ' ' VAL . 17.4 ptpt -81.15 -36.51 30.12 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 117.956 0.344 . . . . 0.0 110.608 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -75.83 -11.25 59.94 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.319 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 162.02 -176.3 38.46 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.77 159.85 51.33 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.549 2.833 . . . . 0.0 110.299 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 31.4 mm -131.89 151.43 35.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 C-N-CA 123.403 0.681 . . . . 0.0 109.498 -177.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.08 -40.76 5.12 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . 0.446 ' HB3' ' CD2' ' B' ' 165' ' ' TYR . 1.0 OUTLIER -168.72 -172.78 1.7 Allowed 'General case' 0 C--O 1.231 0.09 0 CA-C-O 120.963 0.411 . . . . 0.0 111.766 176.639 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 53.5 t -146.71 154.97 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 C-N-CA 124.617 1.167 . . . . 0.0 107.893 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -147.33 153.23 39.45 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 123.223 0.609 . . . . 0.0 109.545 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 48.3 mt -138.71 141.68 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 173.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . . . . . . . . . 9.1 t -119.96 144.46 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.873 0.844 . . . . 0.0 112.33 -174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -134.65 -172.21 2.97 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.578 2.351 . . . . 0.0 108.796 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -134.15 173.09 11.97 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.124 0.964 . . . . 0.0 112.685 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -136.36 -14.25 1.74 Allowed 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 126.206 1.802 . . . . 0.0 112.855 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 72.3 mm-40 -79.28 -53.59 6.79 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.844 -0.535 . . . . 0.0 110.246 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 18.5 t -70.96 -158.09 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 125.216 1.406 . . . . 0.0 109.795 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 89.1 mmt-85 -127.66 11.15 6.7 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.1 0.96 . . . . 0.0 111.041 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 48.4 mtt85 -137.61 174.19 10.85 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.501 1.12 . . . . 0.0 109.409 176.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 89.9 p -79.66 158.74 26.95 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 125.861 1.664 . . . . 0.0 112.265 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.44 ' HD3' " C5'" ' A' ' 4' ' ' ' A' . 93.5 mtt-85 -74.31 -18.84 60.65 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . . . . . . . . . . . 62.2 42.08 99.72 Favored Glycine 0 C--N 1.34 0.791 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.01 172.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.465 ' HB2' ' H ' ' B' ' 124' ' ' GLY . 0.0 OUTLIER -147.05 167.54 23.79 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 118.638 1.219 . . . . 0.0 111.349 -175.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.74 174.41 13.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -168.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.418 ' CZ ' ' CZ ' ' B' ' 161' ' ' PHE . 41.2 m-85 -135.56 162.12 33.57 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 114.067 -1.424 . . . . 0.0 110.092 175.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 97.6 t -141.34 122.27 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.555 1.142 . . . . 0.0 107.961 176.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' B' ' 146' ' ' ASP . 6.1 m-30 -92.09 147.16 23.15 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.215 0.461 . . . . 0.0 110.329 -176.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -127.49 168.65 14.62 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.24 0.616 . . . . 0.0 109.38 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -110.13 -17.43 13.56 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.637 0.256 . . . . 0.0 111.505 -175.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -146.5 142.62 28.25 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.15 0.98 . . . . 0.0 109.008 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 40.4 t -107.93 -13.9 9.98 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -64.88 -3.73 3.72 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.788 0.435 . . . . 0.0 110.288 171.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -140.24 -25.91 0.78 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.37 0.668 . . . . 0.0 111.303 179.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -67.81 -19.04 65.03 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.974 0.807 . . . . 0.0 111.331 175.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -61.29 -24.82 66.68 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.644 0.259 . . . . 0.0 111.427 177.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.52 -31.22 42.13 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 122.289 -0.257 . . . . 0.0 110.328 176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -69.13 -31.37 69.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 122.163 -0.336 . . . . 0.0 111.442 -177.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . 0.485 ' HE2' ' H ' ' B' ' 193' ' ' PHE . 2.9 ptpt -78.9 -45.4 20.69 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.715 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -68.75 -21.48 64.37 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 119.151 -1.02 . . . . 0.0 111.739 -168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 50.7 mmm-85 -90.72 -46.86 8.0 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 123.414 0.686 . . . . 0.0 112.057 178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.56 -4.84 57.13 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -65.19 135.52 55.55 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.699 -0.626 . . . . 0.0 110.121 177.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 62.66 11.58 36.56 Favored Glycine 0 CA--C 1.525 0.689 0 CA-C-O 119.186 -0.785 . . . . 0.0 113.154 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . . . . . . . . . 27.5 ptm -58.86 162.14 4.34 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 118.644 1.222 . . . . 0.0 111.174 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -91.15 137.46 32.35 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 57.9 tp -146.58 -31.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.842 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -148.24 11.74 0.92 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.43 1.092 . . . . 0.0 109.505 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 92.02 2.09 69.34 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 111.699 -0.56 . . . . 0.0 111.699 -176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . 0.42 ' CD ' ' HA ' ' B' ' 126' ' ' SER . 96.0 mtt-85 -79.82 -14.46 58.67 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 114.406 1.261 . . . . 0.0 114.406 -172.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 9.2 mpt_? 48.4 69.7 0.53 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -169.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 21.1 pt -64.06 168.2 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 125.862 1.665 . . . . 0.0 112.087 -169.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 58.4 mtp85 -102.81 130.66 49.88 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 65.9 t -144.17 119.18 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -172.56 179.36 2.48 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.527 -177.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . 0.485 ' H ' ' HE2' ' B' ' 176' ' ' LYS . 20.9 m-85 -46.77 136.62 7.85 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 168.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.5 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 20.9 p -76.0 -69.27 0.51 Allowed 'General case' 0 C--O 1.231 0.117 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -172.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.626 HG12 ' H ' ' B' ' 196' ' ' THR . 12.9 tt 123.6 -173.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 130.312 3.445 . . . . 0.0 106.601 -172.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.626 ' H ' HG12 ' B' ' 195' ' ' ILE . 24.1 p 50.97 9.08 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.735 1.614 . . . . 0.0 114.471 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt 59.66 -57.81 0.06 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.56 2.344 . . . . 0.0 114.136 -175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.501 ' CB ' ' HD2' ' B' ' 199' ' ' PRO . 18.5 ptt180 -165.21 -177.09 0.58 Allowed Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.501 ' HD2' ' CB ' ' B' ' 198' ' ' ARG . 20.7 Cg_endo -59.02 120.79 8.88 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 121.622 1.548 . . . . 0.0 112.797 -177.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . 0.457 ' HB2' " H2'" ' A' ' 5' ' ' ' A' . 13.5 t60 . . . . . 0 C--O 1.254 1.295 0 C-N-CA 128.679 2.792 . . . . 0.0 113.895 169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.724 0 C5'-C4'-C3' 111.1 -2.934 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ' A' . . . . . 0.419 ' N3 ' ' HA2' ' B' ' 124' ' ' GLY . . . . . . . . 0 O4'--C4' 1.416 -3.102 2 O4'-C1'-N19 112.324 4.124 OUTLIER-EPSILON 0.68 1t . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ' G' . . . . . 0.421 ' C6 ' ' CG ' ' B' ' 123' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.918 1 P-O3'-C3' 126.678 5.815 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ' A' . . . . . 0.708 ' N3 ' " H2'" ' A' ' 4' ' ' ' A' . . . . . . . . 0 C5'--C4' 1.544 2.629 2 O4'-C1'-N19 113.036 4.836 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ' A' . . . . . 0.599 HO2' ' H6 ' ' A' ' 6' ' ' ' C' . . . . . . . . 0 C2'--C1' 1.498 -2.993 2 O4'-C1'-N19 116.046 7.846 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ' C' . . . . . 0.599 ' H6 ' HO2' ' A' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.419 -2.842 0 C3'-C2'-C1' 104.601 3.445 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 . . . . . 0 N--CA 1.477 0.913 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -146.44 169.9 17.95 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 123.275 0.63 . . . . 0.0 110.285 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 32.0 m -140.17 9.98 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.498 0.719 . . . . 0.0 111.034 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLY . . . . . . . . . . . . . . . -171.45 19.76 0.07 OUTLIER Glycine 0 CA--C 1.529 0.951 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -149.71 168.57 23.26 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.201 0.6 . . . . 0.0 110.082 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 58.1 ttt85 -145.07 -20.29 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.42 -173.68 3.44 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.311 0.645 . . . . 0.0 109.925 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 58.8 t-20 -49.26 107.79 0.84 Allowed Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.533 1.133 . . . . 0.0 112.047 -177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -82.74 9.96 3.82 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 124.113 3.209 . . . . 0.0 112.768 -174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.48 53.43 3.43 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -172.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -73.84 168.63 24.31 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.679 2.253 . . . . 0.0 109.694 172.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -141.6 -3.32 1.16 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' CYS . . . . . . . . . . . . . 25.5 p -152.74 22.54 0.6 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.297 0.499 . . . . 0.0 111.189 -177.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' CYS . . . . . . . . . . . . . 67.3 m -128.96 75.83 1.68 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 123.744 0.817 . . . . 0.0 109.043 -173.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.413 HD12 ' N ' ' B' ' 120' ' ' LEU . 7.9 mp -83.27 -170.81 3.23 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . 0.404 ' CA ' ' HA ' ' B' ' 163' ' ' PHE . . . -174.36 178.75 46.07 Favored Glycine 0 N--CA 1.448 -0.535 0 O-C-N 121.484 -0.76 . . . . 0.0 112.696 177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' VAL . . . . . . . . . . . . . 19.2 t -130.71 67.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -176.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.485 ' CZ ' ' HA ' ' B' ' 194' ' ' SER . 0.8 OUTLIER -70.49 164.64 24.3 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.411 -176.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' GLY . . . . . 0.419 ' HA2' ' N3 ' ' A' ' 2' ' ' ' A' . . . 138.17 -161.14 25.57 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-O 121.835 0.686 . . . . 0.0 112.238 174.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.79 34.17 5.28 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 113.77 -1.215 . . . . 0.0 108.584 172.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' SER . . . . . . . . . . . . . 15.7 m -75.43 49.87 0.5 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.477 1.111 . . . . 0.0 111.203 177.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' LEU . . . . . 0.413 ' CD1' ' HA3' ' B' ' 160' ' ' GLY . 9.9 mp -58.34 9.75 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.985 1.714 . . . . 0.0 114.66 -174.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -121.49 18.72 11.31 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.024 0.829 . . . . 0.0 111.177 -177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' THR . . . . . . . . . . . . . 86.9 m -116.86 160.33 21.03 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.755 0.822 . . . . 0.0 109.052 175.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 14.6 t -142.1 161.63 37.52 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 122.563 0.345 . . . . 0.0 111.198 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -54.12 -34.27 59.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.812 0.845 . . . . 0.0 112.41 -178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ARG . . . . . . . . . . . . . 88.7 mtm-85 -67.16 -34.16 76.95 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.968 0.507 . . . . 0.0 111.637 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.62 -44.13 35.52 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.46 -28.5 69.71 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.093 0.557 . . . . 0.0 110.734 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -63.01 -24.0 67.71 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -99.3 -33.62 10.65 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.511 0.196 . . . . 0.0 111.096 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.97 -8.94 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.839 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -120.71 -28.4 4.89 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 177.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' SER . . . . . . . . . . . . . 45.7 t -65.08 -15.79 62.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 118.82 0.736 . . . . 0.0 111.571 177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -79.33 -30.81 42.94 Favored 'General case' 0 C--N 1.34 0.189 0 O-C-N 121.785 -0.572 . . . . 0.0 111.009 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -84.9 -14.25 48.35 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 112.37 0.508 . . . . 0.0 112.37 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . 170.13 179.28 41.6 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.8 160.36 49.65 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 123.321 2.681 . . . . 0.0 110.214 178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' ILE . . . . . . . . . . . . . 29.0 mm -127.7 149.03 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -108.93 -45.64 3.76 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -157.71 171.83 19.6 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.926 0.394 . . . . 0.0 110.789 -178.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' VAL . . . . . . . . . . . . . 8.7 p -153.42 153.32 8.95 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.21 1.004 . . . . 0.0 108.377 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' SER . . . . . . . . . . . . . 38.6 t -158.3 154.72 27.59 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.464 0.306 . . . . 0.0 110.922 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' ILE . . . . . . . . . . . . . 53.6 mt -134.38 118.86 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 172.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' VAL . . . . . 0.438 HG22 " H1'" ' A' ' 5' ' ' ' A' . 65.1 t -84.22 116.52 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 124.198 0.999 . . . . 0.0 109.968 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' TYR . . . . . 0.416 ' HB2' ' HA ' ' B' ' 158' ' ' SER . 16.2 p90 -171.45 161.68 6.41 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 123.647 0.592 . . . . 0.0 110.195 175.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -135.61 171.0 15.09 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 122.134 0.969 . . . . 0.0 112.437 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -84.44 -25.71 28.78 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 125.997 1.719 . . . . 0.0 113.098 -176.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -133.13 -57.42 0.91 Allowed 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 123.377 0.671 . . . . 0.0 112.502 -175.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' SER . . . . . . . . . . . . . 61.7 m -49.13 102.83 0.04 OUTLIER 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.853 1.261 . . . . 0.0 110.98 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 39.43 33.88 0.12 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.597 1.559 . . . . 0.0 113.1 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? 51.21 179.78 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.59 1.556 . . . . 0.0 112.73 -174.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' B' ' 151' ' ' TYR . 10.1 p -58.17 119.38 6.74 Favored 'General case' 0 N--CA 1.435 -1.209 0 C-N-CA 124.791 1.236 . . . . 0.0 111.355 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . 0.461 ' HD3' H5'' ' A' ' 4' ' ' ' A' . 89.9 mtt-85 -66.17 -24.54 66.66 Favored 'General case' 0 C--N 1.341 0.198 0 C-N-CA 122.467 0.307 . . . . 0.0 110.199 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLY . . . . . 0.413 ' HA3' ' CD1' ' B' ' 127' ' ' LEU . . . 67.44 31.19 76.19 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 114.557 0.583 . . . . 0.0 114.557 170.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' PHE . . . . . 0.432 ' CE2' ' CZ ' ' B' ' 163' ' ' PHE . 0.3 OUTLIER -131.12 164.02 26.38 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 118.043 0.921 . . . . 0.0 110.03 -175.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.73 174.42 11.23 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -167.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . 0.447 ' CE1' ' HB2' ' B' ' 194' ' ' SER . 61.0 m-85 -140.23 153.03 46.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.734 178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.85 146.27 25.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -130.74 146.44 52.21 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -128.29 167.13 17.35 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.656 0.782 . . . . 0.0 110.198 -170.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -113.26 -13.19 12.97 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.655 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -142.3 137.61 30.72 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.075 0.95 . . . . 0.0 109.095 176.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.412 ' HA ' ' HB3' ' B' ' 172' ' ' ALA . 38.8 t -96.96 -12.9 8.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -66.37 -5.08 9.5 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.033 0.533 . . . . 0.0 110.362 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -136.47 -23.17 1.26 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.413 0.685 . . . . 0.0 111.221 178.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' B' ' 169' ' ' VAL . . . -66.59 -27.9 68.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.503 0.592 . . . . 0.0 110.447 176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -67.2 -27.92 67.66 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 122.19 0.196 . . . . 0.0 111.299 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -79.24 -38.04 36.57 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -67.11 -22.85 65.79 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.333 -0.229 . . . . 0.0 110.66 178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' LYS . . . . . . . . . . . . . 33.5 ttmt -76.92 -49.18 16.19 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -77.39 -24.37 50.54 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.182 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ARG . . . . . . . . . . . . . 38.7 mmt180 -90.3 -47.36 7.81 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' ALA . . . . . . . . . . . . . . . -80.65 -4.79 55.53 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -71.71 135.83 46.98 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.632 0.651 . . . . 0.0 110.193 177.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' GLY . . . . . . . . . . . . . . . 61.04 9.27 13.68 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.894 -0.948 . . . . 0.0 113.627 178.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' MET . . . . . 0.411 ' HG2' HD11 ' B' ' 189' ' ' ILE . 28.7 ptm -62.22 158.26 17.47 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.163 1.481 . . . . 0.0 110.598 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -82.18 129.72 34.91 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 174.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' LEU . . . . . . . . . . . . . 60.8 tp -146.39 -30.88 0.37 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.188 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -144.75 13.27 1.5 Allowed 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 108.95 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.94 19.7 74.67 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.668 -0.573 . . . . 0.0 111.668 -176.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' ARG . . . . . . . . . . . . . 92.0 mtt-85 -114.15 -7.24 13.04 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -173.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 51.84 75.72 0.2 Allowed 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.956 0.903 . . . . 0.0 109.645 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.411 HD11 ' HG2' ' B' ' 182' ' ' MET . 19.6 pt -60.19 176.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 126.094 1.757 . . . . 0.0 114.297 -167.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' ARG . . . . . . . . . . . . . 68.5 mtp85 -118.14 123.85 46.55 Favored 'General case' 0 C--N 1.34 0.187 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' VAL . . . . . . . . . . . . . 61.9 t -141.78 120.74 9.97 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.088 0 CA-C-N 117.888 0.313 . . . . 0.0 111.032 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -179.15 -173.7 0.29 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.479 0.712 . . . . 0.0 110.064 -177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -49.28 141.7 8.28 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 169.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' SER . . . . . 0.485 ' HA ' ' CZ ' ' B' ' 123' ' ' PHE . 54.5 p -75.99 -66.12 0.83 Allowed 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 117.983 -1.008 . . . . 0.0 113.628 -172.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 196' ' ' THR . 8.8 tt 128.82 1.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 130.064 3.346 . . . . 0.0 108.897 -173.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . 0.476 HG23 HG23 ' B' ' 195' ' ' ILE . 4.3 p -141.34 179.9 6.51 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.905 0.882 . . . . 0.0 110.319 -172.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -140.48 100.77 3.95 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.133 0.573 . . . . 0.0 109.578 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' ARG . . . . . 0.471 ' HB3' ' HD2' ' B' ' 199' ' ' PRO . 41.1 mtt85 56.66 166.36 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 125.702 1.601 . . . . 0.0 113.662 -176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' B' ' 198' ' ' ARG . 19.0 Cg_endo -54.66 159.81 8.27 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 123.831 3.021 . . . . 0.0 113.984 -177.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' HIS . . . . . . . . . . . . . 18.1 t60 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 129.512 3.125 . . . . 0.0 113.082 -178.759 . . . . . . . . 0 0 . 1 stop_ save_